<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6099651</article-id><article-id pub-id-type="doi">10.3390/molecules23051061</article-id><article-id pub-id-type="publisher-id">molecules-23-01061</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Essential Oils and Their Constituents Targeting the GABAergic System and Sodium Channels as Treatment of Neurological Diseases</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Ze-Jun</given-names></name><xref rid="c1-molecules-23-01061" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4347-2131</contrib-id><name><surname>Heinbockel</surname><given-names>Thomas</given-names></name><xref rid="c1-molecules-23-01061" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-molecules-23-01061">Department of Anatomy, Howard University College of Medicine, 520 W Str., NW, Washington, DC 20059, USA</aff><author-notes><corresp id="c1-molecules-23-01061"><label>*</label>Correspondence: <email>zejunwang@hotmail.com</email> (Z.-J.W.); <email>theinbockel@howard.edu</email> (T.H.); Tel.: +1-202-8069495 (Z.-J.W.); +1-202-8069873 (T.H.)</corresp></author-notes><pub-date pub-type="epub"><day>02</day><month>5</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2018</year></pub-date><volume>23</volume><issue>5</issue><elocation-id>1061</elocation-id><history><date date-type="received"><day>05</day><month>2</month><year>2018</year></date><date date-type="accepted"><day>27</day><month>4</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 by the authors.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Essential oils and the constituents in them exhibit different pharmacological activities, such as antinociceptive, anxiolytic-like, and anticonvulsant effects. They are widely applied as a complementary therapy for people with anxiety, insomnia, convulsion, pain, and cognitive deficit symptoms through inhalation, oral administration, and aromatherapy. Recent studies show that essential oils are emerging as a promising source for modulation of the GABAergic system and sodium ion channels. This review summarizes the recent findings regarding the pharmacological properties of essential oils and compounds from the oils and the mechanisms underlying their effects. Specifically, the review focuses on the essential oils and their constituents targeting the GABAergic system and sodium channels, and their antinociceptive, anxiolytic, and anticonvulsant properties. Some constituents target transient receptor potential (TRP) channels to exert analgesic effects. Some components could interact with multiple therapeutic target proteins, for example, inhibit the function of sodium channels and, at the same time, activate GABA<sub>A</sub> receptors. The review concentrates on perspective compounds that could be better candidates for new drug development in the control of pain and anxiety syndromes.</p></abstract><kwd-group><kwd>essential oils</kwd><kwd>terpenes</kwd><kwd>GABA receptor</kwd><kwd>sodium channel</kwd><kwd>transient receptor potential (TRP) channel</kwd><kwd>pain</kwd><kwd>epilepsy</kwd><kwd>analgesics</kwd><kwd>anticonvulsant</kwd><kwd>anxiolytic</kwd><kwd>antinociception</kwd><kwd>CNS</kwd><kwd>sensory neurons</kwd></kwd-group></article-meta></front><body><sec id="sec1-molecules-23-01061"><title>1. Introduction</title><p>Essential oils (EOs) are concentrated hydrophobic liquid containing volatile aroma compounds which are extracted from herbs, flowers, and other plant parts. Oil is &#x0201c;essential&#x0201d; in the sense that it contains the &#x0201c;essence of&#x0201d; the plant&#x02019;s fragrance. They are recommended for or encouraged to be applied as a complementary therapy for people with anxiety, pain, bipolar disorder, attention deficit hyperactivity disorder, and depression [<xref rid="B1-molecules-23-01061" ref-type="bibr">1</xref>,<xref rid="B2-molecules-23-01061" ref-type="bibr">2</xref>]. EOs can be absorbed into the body by oral administration, inhalation, diffusers, baths, and massages. Many studies show that EOs were effective in reducing pain, anxiety, and stress symptoms in animal models and humans with different CNS disorders [<xref rid="B1-molecules-23-01061" ref-type="bibr">1</xref>,<xref rid="B2-molecules-23-01061" ref-type="bibr">2</xref>]. EO constituents belong mainly to two chemical groups: terpenoids (monoterpenes and sesquiterpenes) and some phenylpropanoid derivatives. Terpenoid group compounds are usually fairly hydrophobic with molecular weights below 300 Daltons [<xref rid="B3-molecules-23-01061" ref-type="bibr">3</xref>].</p><p>Activation of the &#x003b3;-aminobutyric acid (GABA) receptor system and the blockade of neuronal voltage-gated sodium channels (Na<sup>+</sup> channels) are essential for the overall balance between neuronal excitation and inhibition which is vital for normal brain function and critical for the central nervous system (CNS) disorders. It has been suggested that EO constituents could exert their biological activities through modulating the GABAergic system and inhibiting Na<sup>+</sup> channels [<xref rid="B4-molecules-23-01061" ref-type="bibr">4</xref>,<xref rid="B5-molecules-23-01061" ref-type="bibr">5</xref>]. GABA is the major inhibitory neurotransmitter in the CNS and the GABA receptor system exerts a major inhibitory function in the brain. The dysfunction or deficiency of the GABAergic system has been implicated in epilepsy, pain, and anxiety [<xref rid="B6-molecules-23-01061" ref-type="bibr">6</xref>]. Neuronal voltage-gated Na<sup>+</sup> channels mediate the propagation of action potentials along axons, and thus, are thought to be important targets of antiseizure drugs. Local anesthetics and analgesics prevent the transmission of nerve impulses via their binding to Na<sup>+</sup> channels. Two main types of Na<sup>+</sup> currents, termed tetrodotoxin (TTX)-sensitive and TTX-resistant, have been identified in the dorsal root ganglion [<xref rid="B7-molecules-23-01061" ref-type="bibr">7</xref>,<xref rid="B8-molecules-23-01061" ref-type="bibr">8</xref>]. Studies on Na<sup>+</sup> channels have demonstrated a greater involvement of Nav1.7, a predominant subtype of TTX-sensitive sodium channels expressed principally in peripheral neurons [<xref rid="B8-molecules-23-01061" ref-type="bibr">8</xref>], in inflammatory pain [<xref rid="B9-molecules-23-01061" ref-type="bibr">9</xref>,<xref rid="B10-molecules-23-01061" ref-type="bibr">10</xref>] and in pain sensation [<xref rid="B11-molecules-23-01061" ref-type="bibr">11</xref>,<xref rid="B12-molecules-23-01061" ref-type="bibr">12</xref>]. </p><p>Recently, many studies have addressed the potential of natural EOs for treatment of anxiety, convulsion, and pain in humans and in rodents or fish neuropathic models, and the mechanisms underlying the pharmacological profile. The main constituents of EOs were isolated and chemically elucidated. Recent studies indicate that many EOs and their constituents exert pharmacological properties through interactions with the GABAergic system and voltage-gated Na<sup>+</sup> channels. An increasing number of studies show that: (1) many EOs used for the treatment of anxiety affect the function of the GABAergic system [<xref rid="B13-molecules-23-01061" ref-type="bibr">13</xref>,<xref rid="B14-molecules-23-01061" ref-type="bibr">14</xref>,<xref rid="B15-molecules-23-01061" ref-type="bibr">15</xref>,<xref rid="B16-molecules-23-01061" ref-type="bibr">16</xref>]; (2) many EOs with antinociceptive and anticonvulsant properties inhibit the function of neuronal voltage-gated Na<sup>+</sup> channels [<xref rid="B17-molecules-23-01061" ref-type="bibr">17</xref>]; (3) some EOs affect the function of both the GABAergic system and voltage-gated Na<sup>+</sup> channels [<xref rid="B4-molecules-23-01061" ref-type="bibr">4</xref>,<xref rid="B18-molecules-23-01061" ref-type="bibr">18</xref>].</p><p>This review summarizes the beneficial effects of EOs and their constituents targeting the GABAergic system and neuronal voltage-gated Na<sup>+</sup> channels for CNS disorders, in particular with respect to their antinociceptive, anticonvulsant, anxiolytic, and sedative effects. </p></sec><sec id="sec2-molecules-23-01061"><title>2. The Pharmacological Activities of EOs and the Underlying Mechanism of Their Actions</title><p>The pharmacological activities of EOs, especially antinociceptive, anticonvulsant, anti-inflammatory, anxiolytic, and sedative effects are summarized in <xref rid="molecules-23-01061-t001" ref-type="table">Table 1</xref> which shows the EOs from different plants, their pharmacological activities, and mechanism of actions.</p><sec id="sec2dot1-molecules-23-01061"><title>2.1. EOs with Antinociceptive and Anti-Inflammatory Activities </title><p>EOs that originate from different plants display antinociceptive and anti-inflammatory properties. Bergamot (<italic>Citrus bergamia</italic>) is a fruit best known for its EO used in aromatherapy to minimize symptoms of stress-induced anxiety and mild mood disorders and cancer pain [<xref rid="B29-molecules-23-01061" ref-type="bibr">29</xref>]. The antinociceptive effect of EOs of <italic>Salvia sclarea</italic> (clary sage), <italic>Thymus vulgaris</italic> (thyme), and <italic>Lavandula angustifolia</italic> (true lavender), were examined in the capsaicin test [<xref rid="B29-molecules-23-01061" ref-type="bibr">29</xref>,<xref rid="B47-molecules-23-01061" ref-type="bibr">47</xref>]. The capsaicin test in mice is a reliable model of peripheral nociception, which produces nociceptive behavior similar to that elicited by the intraplantar injection of formalin. Among these EOs, the intraplantar injection of bergamot EO produced a significant antinociceptive effect in mice [<xref rid="B29-molecules-23-01061" ref-type="bibr">29</xref>,<xref rid="B47-molecules-23-01061" ref-type="bibr">47</xref>]. </p><p>EOs from the genus <italic>Artemisia</italic> demonstrated antinociceptive and anti-inflammatory effects. <italic>Artemisia dracunculus</italic> (tarragon) has been used for the treatment of pain and gastrointestinal disturbances in Iranian traditional medicine [<xref rid="B25-molecules-23-01061" ref-type="bibr">25</xref>]. Maham et al. [<xref rid="B25-molecules-23-01061" ref-type="bibr">25</xref>] evaluated both central and peripheral antinociceptive activity of tarragon EO in various experimental models. It was found that the EO possesses a potent antinociceptive effect. Similarly, another EO from <italic>Artemisia ludoviciana</italic> was also reported to possess antinociceptive activity, which was partially mediated by the opioid system [<xref rid="B23-molecules-23-01061" ref-type="bibr">23</xref>]. The aerial parts of <italic>Artemisia herba-alba</italic> are widely used to treat inflammatory disorders (colds, coughing, bronchitis, diarrhea) are infectious diseases (skin diseases, scabies, syphilis). Recent studies showed that appropriate doses of <italic>A. herba-alba</italic> EO displayed both antifungal and anti-inflammatory activities. Thus, the findings justified and reinforced the use of this plant in traditional medicine [<xref rid="B22-molecules-23-01061" ref-type="bibr">22</xref>]. Abu-Darwish et al. [<xref rid="B22-molecules-23-01061" ref-type="bibr">22</xref>] characterized the chemical composition of <italic>A. herba-alba</italic> EO from South Jordan and found that regular monoterpenes were predominant (39.3%) and the principal components were &#x003b1;- and &#x003b2;-thujone (27.7%). <italic>Artemisia judaica L.</italic> is a medicinal and aromatic plant growing in the valley bottoms of desert areas. Abu-Darwish et al. [<xref rid="B24-molecules-23-01061" ref-type="bibr">24</xref>] studied the chemical composition and biological activities of <italic>Artemisia judaica</italic> EO. They found that <italic>A. judaica</italic> EO had antifungal and anti-inflammatory activities. For <italic>A. judaica</italic> EO constituents, oxygenated monoterpenes are a representative group of constituents (68.7%) in the oil with piperitone (30.4%), camphor (16.1%), and ethyl cinnamate (11.0%) as the main compounds.</p><p><italic>Cymbopogon citratus</italic> is widely used in traditional medicine as an infusion or decoction, sedative, and analgesic for treating nervous disturbances [<xref rid="B13-molecules-23-01061" ref-type="bibr">13</xref>]. An antinociceptive effect of EO from <italic>C. citratus</italic> has been detected in the rodent hot plate test, an experimental procedure related to central nervous system activity [<xref rid="B48-molecules-23-01061" ref-type="bibr">48</xref>].</p><p><italic>Dysphania graveolens</italic> is a traditional medicinal plant used in Mexico to treat stomach pain. The EO from the aerial parts of <italic>D. graveolens</italic> was recently evaluated in the hot plate and writhing tests in mice [<xref rid="B33-molecules-23-01061" ref-type="bibr">33</xref>]. The EO produced an antinociceptive response to thermic and chemical stimuli in a mouse model [<xref rid="B33-molecules-23-01061" ref-type="bibr">33</xref>]. </p></sec><sec id="sec2dot2-molecules-23-01061"><title>2.2. EOs with Anxiolytic, Anti-Depressive, and Sedative Activities </title><p>Popular anxiolytic oils include those of <italic>Anthemis nobilis</italic> (chamomile), <italic>Salvia sclarea</italic> (clary), <italic>Rosmarinus officinalis</italic> (rosemary), <italic>Lavandula angustifolia</italic> (lavender), and <italic>Rosa damascena</italic> (rose) [<xref rid="B42-molecules-23-01061" ref-type="bibr">42</xref>]. These EOs have been used medicinally in Europe for thousands of years. In the United States, chamomile is best known as an ingredient in herbal tea preparations advertised as having mild sedation effects. The antidepressant effects of EOs of chamomile (<italic>Anthemis nobilis</italic>), clary (<italic>Salvia sclarea</italic>), rosemary (<italic>Rosmarinus officinalis</italic>), and lavender (<italic>Lavandula angustifolia</italic>) were assessed using a forced swim test (FST) in rats [<xref rid="B42-molecules-23-01061" ref-type="bibr">42</xref>]. It was reported that among the essential oils tested, 5% (<italic>v</italic>/<italic>v</italic>) clary oil had the strongest anti-stressor effect in the FST [<xref rid="B42-molecules-23-01061" ref-type="bibr">42</xref>]. The anti-depressive effect of clary oil in vivo could be blocked by dopaminergic antagonists, suggesting the effect is closely associated with the modulation of the dopaminergic (DA) pathway [<xref rid="B42-molecules-23-01061" ref-type="bibr">42</xref>]. </p><p>The fruits, leaves, and roots of <italic>Piper guineense</italic> have diverse medicinal uses for treating convulsion, rheumatism, and respiratory diseases in African traditional medicine [<xref rid="B2-molecules-23-01061" ref-type="bibr">2</xref>]. The inhalation of <italic>P. guineense</italic> EO had significant sedative and anxiolytic effects, suggesting that the EO might induce a mild tranquilizing effect. The main compounds of <italic>P. guineense</italic> EO were linalool (41.8%) and 3,5-dimethoxytoluene (10.9%). These two main compounds were shown to play a major role in the sedative activity of <italic>P. guineense</italic> EO [<xref rid="B2-molecules-23-01061" ref-type="bibr">2</xref>]. The EO of <italic>Piper guineense</italic> might exert its sedative effects partially via the GABAergic receptor system [<xref rid="B2-molecules-23-01061" ref-type="bibr">2</xref>].</p><p>Komiya et al. [<xref rid="B37-molecules-23-01061" ref-type="bibr">37</xref>] examined the anti-stress action of the EOs of lavender, rose, and lemon using an elevated plus-maze task, a forced swimming task, and an open field task in mice. Among the tested EOs, lemon oil had the strongest anti-stress effect in all three behavioral tasks. Unfortunately, the authors only indicate that the EOs of lavender, rose, and lemon were supplied by Soda Aromatic Co., Ltd. (Tokyo, Japan), but did not mention the botanical origin of EOs. Despite the fact that rose oil did not show a larger anti-stress effect, it has been reported that rose oil had anti-conflict effects and that the effects were not mediated by the benzodiazepine binding site of the GABA<sub>A</sub> receptor complex [<xref rid="B49-molecules-23-01061" ref-type="bibr">49</xref>]. The anxiolytic, antidepressant-like effects of lemon oil were mediated through the suppression of DA activity related to enhanced serotonergic (5-HT) neurons [<xref rid="B37-molecules-23-01061" ref-type="bibr">37</xref>]. Lemon oil can be obtained from a species of the <italic>Citrus</italic> genus [<xref rid="B37-molecules-23-01061" ref-type="bibr">37</xref>]. The EO from <italic>Citrus aurantium</italic> L. was reported to have an anti-stress related effect [<xref rid="B28-molecules-23-01061" ref-type="bibr">28</xref>]. Costa et al. (2013) investigated the anxiolytic-like activity of the EO of <italic>C. aurantium</italic> in a light/dark box, and the antidepressant activity in a forced swim test [<xref rid="B28-molecules-23-01061" ref-type="bibr">28</xref>]. The acute treatment with the EO showed no activity in the forced swim test, which is sensitive to antidepressants. The studies demonstrated that <italic>C. aurantium</italic> EO exhibited an anxiolytic-like activity which was mediated by 5-HT1A-receptors [<xref rid="B28-molecules-23-01061" ref-type="bibr">28</xref>]. The similarity of the mechanism underlying anxiolytic-like activity suggests that lemon oil and EO from <italic>C. aurantium</italic> may present the same bioactive compounds or analogs which target the serotonergic system. The anxiolytic effects of <italic>Citrus sinensis</italic> (sweet orange) EO were evaluated on male Wistar rats in the elevated plus-maze followed by the light/dark paradigm [<xref rid="B30-molecules-23-01061" ref-type="bibr">30</xref>]. At all doses, <italic>C. sinensis</italic> oil demonstrated anxiolytic activity in at least one of the tests and, at the highest dose, it presented significant effects in both animal models [<xref rid="B30-molecules-23-01061" ref-type="bibr">30</xref>].</p><p><italic>Cymbopogon citratus</italic> (DC) Stapf., commonly known as lemongrass, and <italic>Cymbopogon winterianus</italic> Jowitt, are widely used in traditional medicine as an infusion or decoction, sedative, and analgesic for treating nervous disturbances [<xref rid="B13-molecules-23-01061" ref-type="bibr">13</xref>,<xref rid="B50-molecules-23-01061" ref-type="bibr">50</xref>]. The anticonvulsant activities of the EOs from <italic>C. winterianus</italic> and <italic>C. citratus</italic> were evaluated in mice [<xref rid="B32-molecules-23-01061" ref-type="bibr">32</xref>]. The results showed that both EOs were more active on the pentylenetetrazol-induced convulsion model, and <italic>C. citratus</italic> was even more efficient in increasing latency to the first convulsion and latency to death. The mechanism of action of the EOs (<italic>C. citratus</italic> and <italic>C. winterianus</italic>.) for the anticonvulsant effect was, at least in part, dependent upon GABAergic neurotransmission [<xref rid="B32-molecules-23-01061" ref-type="bibr">32</xref>]. Costa et al. [<xref rid="B13-molecules-23-01061" ref-type="bibr">13</xref>] investigated the anxiolytic-like activity of <italic>C. citratus</italic> EO in a light/dark box and marble-burying test and the antidepressant activity was investigated in forced-swimming test model in mice. The results demonstrated that acute treatment with the EO from <italic>C. citratus</italic> was effective against generalized anxiety disorder and epilepsy in experimental procedures in mice [<xref rid="B51-molecules-23-01061" ref-type="bibr">51</xref>]. Studies on the underlying mechanism showed that the anxiolytic-like effect of its EO was mediated by the GABA<sub>A</sub> receptor complex [<xref rid="B13-molecules-23-01061" ref-type="bibr">13</xref>]. The main EO compounds were identified as monoterpene citral (71.29%), a mixture of the stereoisomers geranial and neral, or &#x003b2;-myrcene (16.5%) [<xref rid="B13-molecules-23-01061" ref-type="bibr">13</xref>,<xref rid="B52-molecules-23-01061" ref-type="bibr">52</xref>].</p><p><italic>Asarum heterotropoides</italic> was effective in reducing anxiety and inflammation in relief of pain [<xref rid="B53-molecules-23-01061" ref-type="bibr">53</xref>,<xref rid="B54-molecules-23-01061" ref-type="bibr">54</xref>,<xref rid="B55-molecules-23-01061" ref-type="bibr">55</xref>]. Park et al. (2015) reported that EO of <italic>A. heterotropoides</italic> effectively attenuated depression-like behavior and increased the brain expression of serotonin (5-HT) in response to six minutes of forced swimming or immobilization stress [<xref rid="B26-molecules-23-01061" ref-type="bibr">26</xref>].</p><p>The EO of <italic>Tugetes minutu</italic> L. was found to have anxiogenic-like effects on T-maze and tonic immobility behavior in domestic chicks probably through the negative modulation of GABAergic function [<xref rid="B44-molecules-23-01061" ref-type="bibr">44</xref>]. </p><p><italic>Melissa officinalis</italic> is known to have sedative, cognitive-enhancing, and relevant physiological actions. Abuhamdah et al. [<xref rid="B38-molecules-23-01061" ref-type="bibr">38</xref>] reported that EO from <italic>M. officinalis</italic> reversibly inhibited GABA-induced currents in a concentration-dependent manner whereas no inhibition of NMDA- or AMPA-induced currents was noted. <italic>Lippia alba</italic> (Mill.) N.E. Brown is known as &#x0201c;false-melissa&#x0201d; in Brazil. This plant has been commonly used for its sedative properties, which also have been demonstrated in some rodent studies [<xref rid="B36-molecules-23-01061" ref-type="bibr">36</xref>,<xref rid="B56-molecules-23-01061" ref-type="bibr">56</xref>,<xref rid="B57-molecules-23-01061" ref-type="bibr">57</xref>]. Three main chemotypes obtained from <italic>L. alba</italic> EO were reported and classified according to their major constituent as citral, carvone, and linalool [<xref rid="B56-molecules-23-01061" ref-type="bibr">56</xref>]. Recently, the anesthetic effect of <italic>L. alba</italic> EO was demonstrated in silver catfish and the GABAergic system was involved in this effect [<xref rid="B36-molecules-23-01061" ref-type="bibr">36</xref>]. Thus, the EO of <italic>L. alba</italic> is considered to be a novel natural sedative and anesthetic agent that can be potentially used in aquaculture practices due to its ability to reduce stress in fish with a consequent reduction of economic losses in fish culture [<xref rid="B36-molecules-23-01061" ref-type="bibr">36</xref>]. Meanwhile, repeated treatment with an EO from <italic>L. alba</italic> displayed anxiolytic effects in the elevated T-maze mouse model [<xref rid="B58-molecules-23-01061" ref-type="bibr">58</xref>].</p><p>Lavender (<italic>Lavandula angustifolia</italic>) is cultivated worldwide for its EOs, which are used in perfumes, cosmetics, food processing and, more recently, in aromatherapy products. Lavender inhalation has been used in folk medicine for the treatment of anxiety. It was reported that lavender scent reduces the anxiety state in dental patients [<xref rid="B59-molecules-23-01061" ref-type="bibr">59</xref>]. Chioca et al. [<xref rid="B35-molecules-23-01061" ref-type="bibr">35</xref>] reported that the EO of the plant probably exerted its anxiolytic effect through serotonergic but not GABAergic neurotransmission [<xref rid="B35-molecules-23-01061" ref-type="bibr">35</xref>]. Lavender contains linalool and linalyl acetate as its main bioactive components [<xref rid="B60-molecules-23-01061" ref-type="bibr">60</xref>,<xref rid="B61-molecules-23-01061" ref-type="bibr">61</xref>]. </p><p>Silva et al. [<xref rid="B34-molecules-23-01061" ref-type="bibr">34</xref>] evaluated the sedative and anesthetic properties of <italic>Hyptis mutabilis</italic> EO and the isolated compounds from EO in silver catfish (<italic>Rhamdia quelen</italic>). Both the EO and the isolated compounds [(+)-1-terpinen-4-ol and (&#x02212;)-globulol] showed concentration-dependent sedative and anesthetic effects.</p><p>Coriander volatile oil is prepared from <italic>Coriander sativum</italic>. The oil displays significant anxiolytic- and antidepressant-like effects [<xref rid="B31-molecules-23-01061" ref-type="bibr">31</xref>]. Moreover, coriander volatile oil decreased the catalase activity and increased glutathione level in the hippocampus [<xref rid="B31-molecules-23-01061" ref-type="bibr">31</xref>]. The multiple exposures to coriander volatile oil can be useful as a means to counteract anxiety, depression, and oxidative stress in Alzheimer&#x02019;s disease conditions. The GC-MS and GC-FID analyses determined the main volatile component of the coriander volatile oil sample to be linalool (69.4%), which is probably the responsible constituent for the observed anxiolytic- and antidepressant-like effects. This assumption was confirmed by the fact that inhaling linalool rich EOs can be useful as a means to counteract anxiety [<xref rid="B35-molecules-23-01061" ref-type="bibr">35</xref>,<xref rid="B62-molecules-23-01061" ref-type="bibr">62</xref>]. Other minor constituents of coriander volatile oil are &#x003b1;-pinene (3.0%&#x02013;7.0%) and &#x003b3;-terpinene (1.5&#x02013;8.0%) [<xref rid="B31-molecules-23-01061" ref-type="bibr">31</xref>].</p><p>It was reported that the EO of rhizome and leaf of <italic>Acorus gramineus</italic> displayed sedative and anticonvulsant properties and also anti-oxidative activity after fragrance inhalation [<xref rid="B20-molecules-23-01061" ref-type="bibr">20</xref>]. Koo et al. [<xref rid="B20-molecules-23-01061" ref-type="bibr">20</xref>] reported that pre-inhalation of the EO of <italic>Acorus gramineus</italic> markedly delayed the appearance of pentylenetetrazole-induced convulsion. Moreover, fragrance inhalation progressively prolonged the pentobarbital-induced sleeping time as the inhalation time was lengthened. This sedative effect after inhalation or oral administration of <italic>A. gramineus</italic> EO suggests that this oil may act on the CNS via the GABAergic system. The main components in the EO are &#x003b2;-asarone (40.3%), euasarone (17.0%) and &#x003b1;-euasarone (12.3%) [<xref rid="B20-molecules-23-01061" ref-type="bibr">20</xref>]. </p><p>Valerian (<italic>Valerian officinalis</italic> L), a common name given to the crude drug consisting of the underground organs of species of the genus <italic>Valeriana</italic> (Valerianaceae), demonstrated sedative activity [<xref rid="B46-molecules-23-01061" ref-type="bibr">46</xref>]. The constituents of the volatile oil of valerian are very variable due to population differences in genetics and environmental factors. The major constituents include the monoterpene bornyl acetate and the sesquiterpene valerenic acid, which is characteristic of the species, in addition to other types of sesquiterpene. The non-volatile monoterpenes known as valepotriates were first isolated in 1966 and contribute to the overall activity by possessing sedative activity based on the effects on the CNS [<xref rid="B46-molecules-23-01061" ref-type="bibr">46</xref>]. Valepotriates consist of the furanopyranoid monoterpene skeleton commonly found in the glycosylated forms [<xref rid="B46-molecules-23-01061" ref-type="bibr">46</xref>].</p><p>EO from <italic>Cananga odorata</italic> (ylang-ylang EO, YYO) is usually used in reducing blood pressure, improving cognitive functioning in aromatherapy in humans. It was recently reported that YYO displayed anxiolytic effects on anxiety behaviors [<xref rid="B63-molecules-23-01061" ref-type="bibr">63</xref>]. YYO and the three main constituents of YYO (benzyl benzoate, linalool, and benzyl alcohol) increased the time that mice visited the open arms and a lightbox area in the elevated plus-maze and light-dark box tests after acute and chronic YYO exposures [<xref rid="B63-molecules-23-01061" ref-type="bibr">63</xref>]. YYO and its major constituent benzyl benzoate might act on the serotonergic and dopaminergic pathways [<xref rid="B63-molecules-23-01061" ref-type="bibr">63</xref>].</p><p>A mixture of different EOs was reported to have inhibitory effects on CNS. The central nervous system inhibitory effects of the EO from <italic>SuHeXiang Wan</italic> (Storax pill) on fragrance inhalation (aromatherapy) were evaluated. <italic>SuHeXiang Wan</italic> consists of 15 crude herbs, among them <italic>Liquidambar orientalis</italic>, <italic>Saussurea lappa</italic>, <italic>Aquilaria agallocha</italic>, <italic>Santalum album</italic>, <italic>Boswellia carterii</italic>, <italic>Eugenia caryophyllata</italic>, <italic>Styrax benzoin</italic>, <italic>Dryobalanops aromatica</italic>, and <italic>Cyperus rotundus</italic>. All of them have the term &#x0201c;Xiang&#x0201d; (fragrance) in their Chinese plant names. The fragrance inhalation of the EO from <italic>SuHeXiang Wan</italic> progressively prolonged the pentobarbital-induced sleeping time and inhibited brain lipid peroxidation to which the anticonvulsive action is attributed [<xref rid="B15-molecules-23-01061" ref-type="bibr">15</xref>]. The studies confirm that the inhibitory effects of the EO of <italic>SuHeXiang Wan</italic> on the CNS were mediated by the GABAergic system [<xref rid="B15-molecules-23-01061" ref-type="bibr">15</xref>]. Similarly, the perfume, which is a mixture of different EOs, affects the frame of the human mind. The effects of the perfume and phytoncid on GABA<sub>A</sub> receptors expressed in <italic>Xenopus</italic> oocytes were studied [<xref rid="B40-molecules-23-01061" ref-type="bibr">40</xref>]. The chemical constituents in the perfume such as hinokitiol, pinene, eugenol, citronellol, and citronellal potentiated the GABA<sub>A</sub> receptor expressed in <italic>Xenopus</italic> oocytes. These results suggest that the GABAergic system is a common target of EOs.</p><p>In addition to acting on the GABAergic system, the pharmacological effects of EOs may be mediated through other receptor systems. Different species of <italic>Achillea</italic> are used in folk medicine as sedatives, anti-inflammatory agents, analgesic agents, and anthelmintic (antiparasitic) agents. Majnooni et al. [<xref rid="B19-molecules-23-01061" ref-type="bibr">19</xref>] reported that the EO of <italic>A. wilhelmsii</italic> had anxiolytic effects which were probably not mediated through GABA and opioid receptors. Gas chromatography/mass spectrometry (GC/MS) analysis of the EO showed that the main compounds of the oil were <italic>p</italic>-ocimen (23%), 1, 8-cineole (20.8%), and carvone (19.13%). <italic>Pistacia integerrima</italic> Stewart ex Brandis galls are used in Indian ethnomedicine for their anti-asthmatic, sedative, and spasmolytic properties. The EO of the plant had relaxant and spasmolytic effects which may be mediated by modulating &#x003b2;-adrenoceptors and calcium channels [<xref rid="B41-molecules-23-01061" ref-type="bibr">41</xref>].</p></sec><sec id="sec2dot3-molecules-23-01061"><title>2.3. EOs with Anticonvulsant and Other Pharmacological Properties</title><p>The major chemical components detected in the <italic>Aloysia citrodora</italic> EOs, derived from dried and fresh leaves, included limonene, geranial, neral, 1,8-cineole, curcumene, spathulenol, and caryophyllene oxide, respectively. <italic>A. citrodora</italic> leaf EO inhibited [<sup>3</sup>H] nicotine binding to well-washed rat forebrain membranes, and increased iron-chelation in vitro [<xref rid="B21-molecules-23-01061" ref-type="bibr">21</xref>]. <italic>A. citrodora</italic> EO displays the effective antioxidant, radical-scavenging activities, and significant protective properties [<xref rid="B21-molecules-23-01061" ref-type="bibr">21</xref>].</p><p>Raza et al. [<xref rid="B39-molecules-23-01061" ref-type="bibr">39</xref>] investigated the antiepileptic effects of <italic>Nigella sativa</italic> seed volatile oil and the main components of the oil (that is, thymoquinone, &#x003b1;-pinene and <italic>p</italic>-cymene) using pentylenetetrazole (PTZ) and maximal electroshock (MES)-induced convulsions [<xref rid="B39-molecules-23-01061" ref-type="bibr">39</xref>]. The volatile oil protected mice effectively against PTZ-induced convulsions that may be attributed mainly to its content of thymoquinone and <italic>p</italic>-cymene and to a lesser extent, &#x003b1;-pinene. Volatile oil and its component <italic>p</italic>-cymene effectively suppressed convulsions induced by MES. Their studies suggest that picrotoxin and bicuculline-sensitive GABA receptors mediate an increase in the GABAergic response. </p></sec></sec><sec id="sec3-molecules-23-01061"><title>3. The Pharmacological Properties of Constituents Isolated from EOs and the Underlying Mechanisms of Action</title><p>Natural products have played pivotal roles in neuropharmacology due to their potent and selective targeting of specific biochemical pathways and receptors, and are highly useful as probe substances and therapeutic leads. An increasing amount of evidence shows that EOs present potent bioactive constituents targeting different therapeutic targets [<xref rid="B4-molecules-23-01061" ref-type="bibr">4</xref>,<xref rid="B5-molecules-23-01061" ref-type="bibr">5</xref>]. </p><p>Terpenoids and phenylpropanoid derivatives are the main constituents of EOs [<xref rid="B3-molecules-23-01061" ref-type="bibr">3</xref>]. The most common terpenoids found in EOs are the monoterpenes and the sesquiterpenes. There is increasing interest in the pharmacological actions of the constituents found in EOs, especially terpenes [<xref rid="B3-molecules-23-01061" ref-type="bibr">3</xref>]. Here, we summarize the pharmacological properties of the constituents isolated from EOs and the mechanisms underlying their actions. <xref rid="molecules-23-01061-t002" ref-type="table">Table 2</xref> is a summary of pharmacological properties of EO constituents from different plants and the underlying mechanisms of their effects.</p><sec id="sec3dot1-molecules-23-01061"><title>3.1. Analgesic and Anticonvulsant Properties</title><p>The main components of the EOs of aromatic plants, terpenes, and terpenoids are considered important agents in the food industry and for medicinal use. The constituents of the EOs of aromatic plants are emerging therapeutic resources for developing new drugs to treat chronic pain [<xref rid="B95-molecules-23-01061" ref-type="bibr">95</xref>]. An increasing number of terpenes and terpenoids are found to have analgesic anti-inflammatory properties.</p><sec id="sec3dot1dot1-molecules-23-01061"><title>3.1.1. Terpenoids with Analgesic Properties Targeting Na<sup>+</sup> and TRP Channels</title><p>1,8-Cineole is a terpenoid present in many EOs of plants with several pharmacological and biological effects, including antinociceptive, smooth muscle relaxant, and ion channel action. Additionally, 1,8-cineole blocked action potentials, thereby reducing the excitability of peripheral neurons [<xref rid="B96-molecules-23-01061" ref-type="bibr">96</xref>,<xref rid="B97-molecules-23-01061" ref-type="bibr">97</xref>]. Ferreira-da-Silva et al. [<xref rid="B64-molecules-23-01061" ref-type="bibr">64</xref>] demonstrated that 1,8-cineole directly affects Na<sup>+</sup> channels of the superior cervical ganglion neurons by modifying several gating parameters that are likely to be the major cause of excitability blockade. Eucalyptol reduced the excitability of rat sciatic nerve and superior cervical ganglion neurons [<xref rid="B96-molecules-23-01061" ref-type="bibr">96</xref>,<xref rid="B97-molecules-23-01061" ref-type="bibr">97</xref>]. On the other hand, Zeraatpisheh and Vatanparast [<xref rid="B65-molecules-23-01061" ref-type="bibr">65</xref>] reported that 1,8-cineole (eucalyptol) induced hyperexcitability and epileptiform activity in snail neurons, which is most likely mediated through the direct inhibitory action on the potassium channels.</p><p>Menthol (2-isopropyl-5-methylcyclohexanol), which is contained in peppermint or other mint oils, is well-known to induce analgesia by activating the transient receptor potential (TRP) melastatin-8 (TRPM8) channels [<xref rid="B86-molecules-23-01061" ref-type="bibr">86</xref>]. By recording the compound action potentials (CAPs), Kawasaki et al. [<xref rid="B86-molecules-23-01061" ref-type="bibr">86</xref>] examined the effects of menthol and its related compounds on CAP peak amplitude. (&#x02212;)-Menthol and (+)-menthol concentration-dependently reduced the CAP peak amplitude. (&#x02212;)-Menthone, (+)-menthone, (&#x02212;)-carvone, (+)-carvone, (+)-carveol, and (+)-pulegone inhibited CAPs with extents similar to that of menthol (see <xref ref-type="fig" rid="molecules-23-01061-f001">Figure 1</xref>) [<xref rid="B86-molecules-23-01061" ref-type="bibr">86</xref>]. They found that menthol and its related compounds reduce CAP peak amplitude in a manner specifically related to their chemical structures and that menthol activity is not mediated by TRPM8 channels [<xref rid="B86-molecules-23-01061" ref-type="bibr">86</xref>].</p><p>Terpenoids (for example, 1,8-cineole, linalool and linalyl acetate) are the main chemical components of EOs of the <italic>Lavandula</italic> genus, which includes lavender (<italic>Lavandula angustifolia</italic>), lavandin (<italic>L. angustifolia hybrid L. latifolia</italic>), and bergamot (<italic>Citrus bergamia</italic>). Lavandin is actually a hybrid created from true lavender (<italic>L. augustifolia</italic>) and spike lavender (<italic>L. latifolia)</italic>. Even though the EO containing linalool and/or linalyl acetate demonstrated an antinociceptive effect [<xref rid="B47-molecules-23-01061" ref-type="bibr">47</xref>], the main constituents of the EO, linalool and linalyl acetate (<xref ref-type="fig" rid="molecules-23-01061-f001">Figure 1</xref>), were much more potent than the bergamot EO or other EOs in inhibiting the response to intraplantar capsaicin [<xref rid="B29-molecules-23-01061" ref-type="bibr">29</xref>,<xref rid="B47-molecules-23-01061" ref-type="bibr">47</xref>,<xref rid="B98-molecules-23-01061" ref-type="bibr">98</xref>]. Linalool has been the compound mostly linked to the anxiolytic effect of lavender [<xref rid="B35-molecules-23-01061" ref-type="bibr">35</xref>,<xref rid="B60-molecules-23-01061" ref-type="bibr">60</xref>,<xref rid="B61-molecules-23-01061" ref-type="bibr">61</xref>,<xref rid="B62-molecules-23-01061" ref-type="bibr">62</xref>,<xref rid="B99-molecules-23-01061" ref-type="bibr">99</xref>,<xref rid="B100-molecules-23-01061" ref-type="bibr">100</xref>,<xref rid="B101-molecules-23-01061" ref-type="bibr">101</xref>]. Moreover, Takahashi et al. [<xref rid="B60-molecules-23-01061" ref-type="bibr">60</xref>] showed that the anxiolytic-like effect of linalool in mice tested in the elevated plus-maze was potentiated by linalyl acetate. Also, it was reported that linalool displayed depressant effects on the central nervous system and olfactory receptors [<xref rid="B85-molecules-23-01061" ref-type="bibr">85</xref>]. Leal-Cardoso et al. [<xref rid="B85-molecules-23-01061" ref-type="bibr">85</xref>] investigated the effects of linalool on the excitability of peripheral neurons of the somatic sensory system. They found that linalool acts on the somatic sensory system with local anesthetic properties since it blocked the action potential by acting on voltage-dependent Na<sup>+</sup> channels. </p><p>Carvacrol (5-isopropyl-2-methylphenol) (see <xref ref-type="fig" rid="molecules-23-01061-f001">Figure 1</xref>) is a monoterpenic phenol present in the EOs of many plants, especially in the genera <italic>Origanum</italic> and <italic>Thymus</italic> [<xref rid="B81-molecules-23-01061" ref-type="bibr">81</xref>]. It is the major constituent of the EO fraction of oregano and thyme. Carvacrol has attracted attention because of its beneficial biological activities, especially analgesic activity. Gon&#x000e7;alves et al. [<xref rid="B45-molecules-23-01061" ref-type="bibr">45</xref>] characterized the constituents of <italic>Thymus capitatus</italic> EO and evaluated their antinociceptive activity by in vivo and in vitro procedures. The EO of <italic>T. capitatus</italic> presented 33 components, mainly monoterpenes and sesquiterpenes, and carvacrol (80%) was its major constituent. EO of <italic>T. capitatus</italic> dose-dependently decreased the CAP amplitude. Such activity was presumably mediated through voltage-gated Na<sup>+</sup> channels [<xref rid="B45-molecules-23-01061" ref-type="bibr">45</xref>]. Melo et al. [<xref rid="B81-molecules-23-01061" ref-type="bibr">81</xref>] examined the behavioral effects of carvacrol using elevated plus-maze (EPM), open field, rotarod, and barbiturate-induced sleeping time tests in mice. The results indicate that carvacrol had anxiolytic effects in the plus-maze test which are not influenced by the locomotor activity in the open-field test [<xref rid="B81-molecules-23-01061" ref-type="bibr">81</xref>]. The mechanism underlying the anesthetic and analgesic effects is based on a reduction in neuronal excitability and voltage-gated Na<sup>+</sup> channel inhibition in peripheral neurons [<xref rid="B79-molecules-23-01061" ref-type="bibr">79</xref>]. The hypothesis of the underlying mechanism was supported by the finding that carvacrol could reduce the total voltage-gated Na<sup>+</sup> current and tetrodotoxin-resistant (TTX-R) Na<sup>+</sup> current component in a concentration-dependent manner in isolated dorsal root ganglion neurons [<xref rid="B80-molecules-23-01061" ref-type="bibr">80</xref>]. In addition to analgesic activity mediated through the blockade of Na<sup>+</sup> channels [<xref rid="B45-molecules-23-01061" ref-type="bibr">45</xref>,<xref rid="B80-molecules-23-01061" ref-type="bibr">80</xref>], Trailovi&#x00107; et al. [<xref rid="B78-molecules-23-01061" ref-type="bibr">78</xref>] tested the effects of different concentrations of carvacrol on isolated tissues of the large pig nematode <italic>Ascaris suum</italic>. The somatic muscle flaps were used for contraction assays and for electrophysiological investigations. The inhibitory effect of carvacrol on contractions, the inhibition of depolarizations caused by acetylcholine (ACh), and the reduction of conductance changes directly point to an interaction with nicotinic ACh receptors in <italic>A. suum</italic>.</p><p>Bisabolol, or more formally &#x003b1;-(&#x02212;)-bisabolol or also known as levomenol, is a natural monocyclic sesquiterpene alcohol (<xref ref-type="fig" rid="molecules-23-01061-f001">Figure 1</xref>). It is a primary constituent of the essential oil from <italic>Matricaria chamomilla</italic> [<xref rid="B74-molecules-23-01061" ref-type="bibr">74</xref>]. Bisabolol is known to have anti-irritant, anti-inflammatory, and anti-microbial properties. Recently, it was reported that bisabolol demonstrated an antinociceptive-like effect which could be associated with decreased peripheral nerve excitability [<xref rid="B74-molecules-23-01061" ref-type="bibr">74</xref>]. The decreased nervous excitability elicited by &#x003b1;-(&#x02212;)-bisabolol might be caused by an irreversible blockade of voltage-dependent Na<sup>+</sup> channels [<xref rid="B74-molecules-23-01061" ref-type="bibr">74</xref>].</p><p>Estragole, a volatile terpenoid, is the primary constituent of EO of tarragon (comprising 60&#x02013;75%). It has several pharmacological and biological activities, including antioxidant, anxiolytic, and antimicrobial activities [<xref rid="B82-molecules-23-01061" ref-type="bibr">82</xref>]. The mechanism of action of estragole on neuronal excitability was recently investigated. The intact and dissociated dorsal root ganglion neurons of rats were used to record action potential and Na<sup>+</sup> currents with intracellular and patch-clamp techniques, respectively. It was found that estragole blocked neuronal excitability by direct inhibition of Na<sup>+</sup> channel conductance activation. </p><p>Carvone (<italic>p</italic>-mentha-6,8-dien-2-one) (<xref ref-type="fig" rid="molecules-23-01061-f001">Figure 1</xref>) is a chiral monoterpene ketone that is present in <italic>Mentha spicata</italic> (Spearmint) and <italic>Carum carvi</italic> (Caraway) EOs and has been shown to have anticonvulsant [<xref rid="B102-molecules-23-01061" ref-type="bibr">102</xref>], antinociceptive [<xref rid="B103-molecules-23-01061" ref-type="bibr">103</xref>] and anxiolytic-like effects in the elevated T maze [<xref rid="B58-molecules-23-01061" ref-type="bibr">58</xref>]. Both (<italic>R</italic>)-(&#x02212;)-carvone and (<italic>S</italic>)-(+)-carvone decreased peripheral nerve activity, likely through the blockade of voltage-gated Na<sup>+</sup> channels [<xref rid="B77-molecules-23-01061" ref-type="bibr">77</xref>,<xref rid="B104-molecules-23-01061" ref-type="bibr">104</xref>]. (<italic>S</italic>)-(+)-Carvone appears to have anticonvulsant activity against pentylenetetrazole- and picrotoxin-induced seizures [<xref rid="B102-molecules-23-01061" ref-type="bibr">102</xref>]. In vivo, both (<italic>R</italic>)-(&#x02212;)-carvone and (<italic>S</italic>)-(+)-carvone display antimanic-like effects in two mouse models [<xref rid="B77-molecules-23-01061" ref-type="bibr">77</xref>].</p><p>Kang et al. [<xref rid="B105-molecules-23-01061" ref-type="bibr">105</xref>] examined the effects of (&#x02212;)-carvone and its stereoisomer (+)-carvone (in caraway) on glutamatergic spontaneous excitatory transmission in SG neurons of adult rat spinal cord slices by using the whole-cell patch-clamp technique. They found that (&#x02212;)-carvone and (+)-carvone activate TRPV1 and TRPA1 channels, respectively, resulting in an increase in spontaneous L-glutamate release onto SG neurons, with almost the same efficacy [<xref rid="B105-molecules-23-01061" ref-type="bibr">105</xref>].</p><p>Terpinen-4-ol (<xref ref-type="fig" rid="molecules-23-01061-f001">Figure 1</xref>) is a monoterpenoid alcoholic component of EOs obtained from several aromatic plants. N&#x000f3;brega et al. [<xref rid="B90-molecules-23-01061" ref-type="bibr">90</xref>] investigated the psychopharmacological and electrophysiological activities of Terpinen-4-ol in male Swiss mice and Wistar rats [<xref rid="B90-molecules-23-01061" ref-type="bibr">90</xref>]. Terpinen-4-ol (<italic>i.p.</italic>) inhibited pentylenetetrazol-(PTZ-) induced seizures, indicating anticonvulsant effects. The anticonvulsant action exerted by Terpinen-4-ol involved the GABAergic system but did not bind to the benzodiazepine-binding site of GABA<sub>A</sub> receptors [<xref rid="B90-molecules-23-01061" ref-type="bibr">90</xref>]. Furthermore, the electrophysiological results show that terpinen-4-ol decreased a sodium current through voltage-dependent sodium channels [<xref rid="B103-molecules-23-01061" ref-type="bibr">103</xref>]. Thus, its anticonvulsant effect may be related to changes in neuronal excitability based on the modulation of both the GABAergic system and Na<sup>+</sup> channels. </p></sec><sec id="sec3dot1dot2-molecules-23-01061"><title>3.1.2. Terpenes with Analgesic and Anticonvulsant Properties Targeting GABA<sub>A</sub> Receptors</title><p>Hossain et al. [<xref rid="B27-molecules-23-01061" ref-type="bibr">27</xref>] electrophysiologically tested the effect of fragrant compounds in oolong tea on GABA<sub>A</sub> receptors which were expressed in <italic>Xenopus oocytes</italic>. Oolong tea is a traditional Chinese tea that is made by withering the plants with strong sun exposure and oxidation. <italic>cis</italic>-Jasmone, jasmine lactone, linalool oxide, and methyl jasmonate significantly potentiated the response to GABA. The inhalation of 0.1% cis-jasmone or methyl jasmonate significantly increased the sleeping time of mice induced by pentobarbital. The results suggest that these fragrant compounds could be absorbed by the brain and thereby potentiated the GABA<sub>A</sub> receptor response to exerting a tranquilizing effect on the brain [<xref rid="B27-molecules-23-01061" ref-type="bibr">27</xref>].</p><p>Nerolidol is an acyclic sesquiterpene found as a major constituent of several EOs such as <italic>Piper claussenianum</italic> and <italic>Burchardia umbellata</italic> [<xref rid="B89-molecules-23-01061" ref-type="bibr">89</xref>]. Fons&#x000ea;ca et al. [<xref rid="B89-molecules-23-01061" ref-type="bibr">89</xref>] evaluated the antinociceptive activity of nerolidol using the acetic acid-induced writhing test, the formalin test, and the hot-plate test. The results showed that nerolidol had antinociceptive activities in chemical nociception models (acetic acid-induced writhing test and formalin test), but not in the thermal nociception model (hotplate test). The analgesic activity of nerolidol is possibly related to the GABAergic system, and not to the opioidergic system or to ATP-sensitive K<sup>+</sup>-channels [<xref rid="B89-molecules-23-01061" ref-type="bibr">89</xref>]. </p><p>Natural borneol is (+)-borneol (<xref ref-type="fig" rid="molecules-23-01061-f002">Figure 2</xref>). (+)-Borneol is a bicyclic monoterpene present in the EOs of numerous medicinal plants, including valerian (<italic>Valeriana officinalis</italic>), chamomile (<italic>Matricaria chamomilla</italic>), and lavender (<italic>Lavandula officinalis</italic>). It is used for analgesia and anesthesia in traditional Chinese medicine [<xref rid="B69-molecules-23-01061" ref-type="bibr">69</xref>]. (+)-Borneol has remarkable anti-hyperalgesic effects on neuropathic and inflammatory pain in animal models [<xref rid="B69-molecules-23-01061" ref-type="bibr">69</xref>]. The results suggest that (+)-borneol may ameliorate mechanical hyperalgesia by enhancing GABA<sub>A</sub>R-mediated GABAergic transmission in the spinal cord and could serve as a therapeutic for chronic pain [<xref rid="B69-molecules-23-01061" ref-type="bibr">69</xref>]. Granger et al. [<xref rid="B14-molecules-23-01061" ref-type="bibr">14</xref>] reported that both (+)-borneol and its enantiomer (&#x02212;)-borneol directly potentiate GABA activity at recombinant human &#x003b1;<sub>1</sub>&#x003b2;<sub>2</sub>&#x003b3;<sub>2L</sub> GABA<sub>A</sub> receptors are expressed in <italic>Xenopus laevis</italic> oocytes. Both (+)-borneol and (&#x02212;)-borneol demonstrated a highly efficacious positive modulating action at GABA<sub>A</sub> receptors [<xref rid="B14-molecules-23-01061" ref-type="bibr">14</xref>]. In vivo, (+)-borneol displays significant antinociceptive effect in models of chronic pain in mice without producing a motor deficit. These findings suggest that borneol may ameliorate mechanical hyperalgesia by enhancing GABA<sub>A</sub>R-mediated GABAergic transmission in the spinal cord and could serve as a therapeutic for chronic pain.</p><p>Thymol is a monoterpenoid monocyclic phenolic compound. It is the main component of the EO of <italic>Thymus vulgaris</italic> (Lamiaceae). The main therapeutic application of thymol is in dental preparations to kill odor-producing bacteria and has various actions including antinociception and nerve conduction inhibition [<xref rid="B92-molecules-23-01061" ref-type="bibr">92</xref>,<xref rid="B93-molecules-23-01061" ref-type="bibr">93</xref>,<xref rid="B106-molecules-23-01061" ref-type="bibr">106</xref>]. Thymol has been reported to activate transient receptor potential (TRP) channels expressed in heterologous cells [<xref rid="B107-molecules-23-01061" ref-type="bibr">107</xref>] and act as a positive allosteric modulator of human GABA<sub>A</sub> receptors and a homo-oligomeric GABA receptor from Drosophila melanogaster [<xref rid="B93-molecules-23-01061" ref-type="bibr">93</xref>]. Thymol displayed inhibition on spontaneous excitatory transmission in adult rat spinal substantia gelatinosa (SG) neurons, suggesting that thymol increases the spontaneous release of <sc>l</sc>-glutamate onto the neurons by activating TRPA1 channels while producing an outward current without TRP activation [<xref rid="B92-molecules-23-01061" ref-type="bibr">92</xref>]. Considering that the substantia gelatinosa plays a pivotal role in modulating nociceptive transmission from the periphery, the actions of thymol could contribute to at least a part of its antinociceptive effect [<xref rid="B92-molecules-23-01061" ref-type="bibr">92</xref>].</p><p>Isopulegol (<italic>p</italic>-menth-8-en-3-ol) (<xref ref-type="fig" rid="molecules-23-01061-f002">Figure 2</xref>), a monoterpene alcohol of the menthane family, is present in the EOs of various plants species, such as <italic>Eucalyptus citriodora</italic> and <italic>Zanthoxylum schinifolium</italic> [<xref rid="B84-molecules-23-01061" ref-type="bibr">84</xref>]. It was found that similar to diazepam, isopulegol significantly prolonged the latency for convulsions and mortality of mice in a PTZ-induced convulsion animal model [<xref rid="B84-molecules-23-01061" ref-type="bibr">84</xref>]. The results suggest that the anticonvulsant effects of isopulegol against PTZ-induced convulsions are possibly related to positive modulation of benzodiazepine-sensitive GABA<sub>A</sub> receptors [<xref rid="B84-molecules-23-01061" ref-type="bibr">84</xref>].</p></sec><sec id="sec3dot1dot3-molecules-23-01061"><title>3.1.3. Phenylpropanoid Derivative Constituents with Analgesic Properties and the Mechanisms of Action</title><p>Methyleugenol (4-allyl-1,2-dimethoxybenzene) (<xref ref-type="fig" rid="molecules-23-01061-f003">Figure 3</xref>), a phenylpropanoid derivative, is a natural constituent isolated from EOs of many plants, such as Chinese herb <italic>Asari Radix et Rhizoma</italic>, having multiple biological effects including anticonvulsant, antinociceptive, and anesthetic activities. The anesthetic property of methyleugenol has been demonstrated by a loss of the righting reflex and decreased sensitivity to a tail pinch in rats and mice, and a loss of the corneal reflex in rabbits [<xref rid="B5-molecules-23-01061" ref-type="bibr">5</xref>]. The antinociceptive and anesthetic effects of methyleugenol resulted from the inhibitory action of methyleugenol on peripheral Na<sup>+</sup> channels [<xref rid="B5-molecules-23-01061" ref-type="bibr">5</xref>]. Yano et al. [<xref rid="B88-molecules-23-01061" ref-type="bibr">88</xref>] tested the effects of methyleugenol on antinociception using the formalin test in mice in vivo. They found that the antinociceptive effect of methyleugenol on the second phase of formalin-induced pain might be due to the inhibition of NMDA receptor-mediated hyperalgesia via GABA<sub>A</sub> receptors. Ding et al. [<xref rid="B87-molecules-23-01061" ref-type="bibr">87</xref>] tested the action of methyleugenol on GABA<sub>A</sub> receptors. At lower concentrations (~30 &#x003bc;M), methyleugenol significantly potentiated GABA-induced currents in cultured hippocampal neurons [<xref rid="B87-molecules-23-01061" ref-type="bibr">87</xref>]. Similarly, methyleugenol potentiated GABA-induced currents mediated by recombinant &#x003b1;<sub>1</sub>&#x003b2;<sub>2</sub>&#x003b3;<sub>2</sub> or &#x003b1;<sub>5</sub>&#x003b2;<sub>2</sub>&#x003b3;<sub>2</sub> GABA<sub>A</sub>Rs in human embryonic kidney (HEK) cells. In addition to the blockade of Na<sup>+</sup> channels [<xref rid="B5-molecules-23-01061" ref-type="bibr">5</xref>], this study adds GABA<sub>A</sub>R activation to the list of molecular targets of methyleugenol [<xref rid="B87-molecules-23-01061" ref-type="bibr">87</xref>].</p><p>Eugenol (4-allyl-2-methoxyphenol) (<xref ref-type="fig" rid="molecules-23-01061-f003">Figure 3</xref>), an aromatic phenylpropanoid molecule found in plants including <italic>Syzygium aromaticum</italic> (Clove), has been used in medicine to relieve pain [<xref rid="B43-molecules-23-01061" ref-type="bibr">43</xref>]. The EO of clove, which is made from the aromatic flower buds of a tree in the family Myrtaceae, <italic>Syzygium aromaticum</italic>, is known as an important weak local anesthetic for dental pain [<xref rid="B17-molecules-23-01061" ref-type="bibr">17</xref>,<xref rid="B43-molecules-23-01061" ref-type="bibr">43</xref>]. Eugenol possesses analgesic effects that may be related to the inhibition of voltage-dependent Na<sup>+</sup> channels and/or to the activation of TRPV1 receptors or both. Moreira-Lobo et al. [<xref rid="B17-molecules-23-01061" ref-type="bibr">17</xref>] reported that eugenol inhibited action potentials and modified the excitability of the rat sciatic nerve and superior cervical ganglion neurons. Huang et al. [<xref rid="B43-molecules-23-01061" ref-type="bibr">43</xref>] reported that eugenol reduced the firing of neuronal action potentials and hyperexcitability through a synergistic blocking effect of Na<sup>+</sup> currents. Recently, Vatanparast et al. [<xref rid="B83-molecules-23-01061" ref-type="bibr">83</xref>] studied the effects of eugenol on the excitability of central neurons of the land snail <italic>Caucasotachea atrolabiata</italic> and the underlying ionic mechanisms. It was found that a low concentration of eugenol could have antiepileptic properties, while at a higher concentration, it induced epileptiform activity. The dose-dependent inhibition of the ionic currents underlying the rising and falling phases of the action potential seems to be relevant to the eugenol suppressant and excitatory actions, respectively [<xref rid="B83-molecules-23-01061" ref-type="bibr">83</xref>].</p></sec></sec><sec id="sec3dot2-molecules-23-01061"><title>3.2. Anxiolytic, Sedative, and Anti-Depressive Properties </title><p>EOs with anxiolytic, anti-depressive, and sedative properties usually interact with the GABAergic system. Some constituents contained in the EOs might act on the GABAergic system to exert their pharmacological effects.</p><sec id="sec3dot2dot1-molecules-23-01061"><title>3.2.1. Terpenes with Anxiolytic and Sedative Properties Targeting the GABAergic System</title><p>An increasing number of terpenes have been reported to have anxiolytic and sedative activities. A promising line of research on terpenes has attributed the sedative and anxiolytic effects to the modulation of GABA<sub>A</sub> receptor function [<xref rid="B16-molecules-23-01061" ref-type="bibr">16</xref>].</p><p>The monoterpene (+)-limonene (<xref ref-type="fig" rid="molecules-23-01061-f004">Figure 4</xref>), a chemical constituent of various bioactive EOs, is the major chemical component (58.4%) of the <italic>Citrus aurantifolia</italic> EO [<xref rid="B108-molecules-23-01061" ref-type="bibr">108</xref>]. The anxiolytic-like properties of <italic>Citrus</italic> EOs from <italic>C. aurantium</italic> L. and sweet orange aroma have been demonstrated in rodent models [<xref rid="B30-molecules-23-01061" ref-type="bibr">30</xref>,<xref rid="B109-molecules-23-01061" ref-type="bibr">109</xref>]. Bergamot (<italic>C. bergamia</italic>) is a fruit best known for its EO. The oil is used in aromatherapy to minimize symptoms of stress-induced anxiety and mild mood disorders and cancer pain [<xref rid="B29-molecules-23-01061" ref-type="bibr">29</xref>]. The anxiolytic-like effects of (+)-limonene were reported in an elevated maze model of anxiety in mice. However, the molecular target protein of the compound was not studied in that report [<xref rid="B72-molecules-23-01061" ref-type="bibr">72</xref>]. s-Limonene is a component of lemon EO. The studies on the anti-stress effect of s-Limonene suggest that the effect may be mediated through the GABAergic system [<xref rid="B71-molecules-23-01061" ref-type="bibr">71</xref>]. </p><p>(+)-Dehydrofukinone (<xref ref-type="fig" rid="molecules-23-01061-f004">Figure 4</xref>), also known as dihydrokaranone, is an eremophilane-type sesquiterpenoid ketone isolated from <italic>Nectandra grandiflora</italic> Ness (Lauraceae) EO. Recent behavioral studies have indicated that dehydrofukinone has sedative and anesthetic properties mediated by GABAergic mechanisms in fish [<xref rid="B70-molecules-23-01061" ref-type="bibr">70</xref>], and induces sedation and anesthesia by modulation of GABA<sub>A</sub> receptors in a mouse model [<xref rid="B73-molecules-23-01061" ref-type="bibr">73</xref>], suggesting that the natural compound (+)-dehydrofukinone has therapeutic potential as a suppressor of neuronal excitability.</p><p>Thymoquinone (<xref ref-type="fig" rid="molecules-23-01061-f004">Figure 4</xref>), a major constituent of <italic>Nigella sativa</italic> seeds EO (27.6&#x02013;57.0%), exhibits anticonvulsant activity in the PTZ-induced seizure model [<xref rid="B94-molecules-23-01061" ref-type="bibr">94</xref>]. The anticonvulsant effects are probably mediated through an opioid receptor-mediated increase in GABAergic tone. Gilhotra and Dhingra [<xref rid="B110-molecules-23-01061" ref-type="bibr">110</xref>] investigated the role of GABAergic and nitriergic modulation in the antianxiety effect of thymoquinone. Thymoquinone (20 mg/kg) showed anxiolytic effects with a significant decrease in plasma nitrite and the reversal of decreased brain GABA content in stressed mice [<xref rid="B110-molecules-23-01061" ref-type="bibr">110</xref>].</p><p>Pine EO was reported to have anti-inflammatory, antimicrobial, analgesic, and anti-stress effects [<xref rid="B75-molecules-23-01061" ref-type="bibr">75</xref>,<xref rid="B111-molecules-23-01061" ref-type="bibr">111</xref>,<xref rid="B112-molecules-23-01061" ref-type="bibr">112</xref>]. The main components in the oil are &#x003b1;- and &#x003b2;-pinene, 3-carene, limonene, and terpinene [<xref rid="B113-molecules-23-01061" ref-type="bibr">113</xref>]. &#x003b1;-Pinene [2,6,6,-trimethylbicyclo(3.1.1)-2-hept-2-ene] (<xref ref-type="fig" rid="molecules-23-01061-f003">Figure 3</xref>), a major monoterpene of pine EOs, shows anxiolytic and hypnotic effects upon inhaled administration and a sleep enhancing property through a direct binding to GABA<sub>A</sub> receptors by acting as a partial modulator of GABA<sub>A</sub> receptors [<xref rid="B75-molecules-23-01061" ref-type="bibr">75</xref>]. </p><p>Sideritis plants and their extracts have been used in traditional medicine as sedatives, anxiolytics, and anticonvulsant agents. Kessler et al. [<xref rid="B114-molecules-23-01061" ref-type="bibr">114</xref>] demonstrated that volatile aroma substances in sideritis tea extracts have a powerful modulatory effect on synaptic &#x003b1;<sub>1</sub>/&#x003b2;<sub>2</sub>GABA<sub>A</sub>Rs (with or without &#x003b3;<sub>2</sub> subunits) in a heterologous expression system. Pinenes are the most prevalent of the volatile aroma components in Siderites extracts and the pinene metabolites myrtenol and verbenol (<xref ref-type="fig" rid="molecules-23-01061-f004">Figure 4</xref>) have been identified as the most potent positive allosteric modulators of synaptic-type GABA<sub>A</sub> receptors composed of &#x003b1;<sub>1</sub>&#x003b2;<sub>2</sub> and &#x003b1;<sub>1</sub>&#x003b2;<sub>2</sub>&#x003b3;<sub>2</sub> subunits [<xref rid="B114-molecules-23-01061" ref-type="bibr">114</xref>]. van Brederode et al. [<xref rid="B16-molecules-23-01061" ref-type="bibr">16</xref>] examined the two terpenoids, myrtenol, and verbenol and found augmented tonic GABA currents mediated by extrasynaptic GABA<sub>A</sub> receptors containing the &#x003b4; subunit. It was reported that terpenoid substances potentiated the response to GABA in HEK293 cells transfected with GABA<sub>A</sub>Rs composed of subunits that typically mediate tonic GABA inhibition in the brain. Their results suggest that myrtenol and verbenol act as positive allosteric modulators at synaptic and extrasynaptic GABA<sub>A</sub> receptors, thereby augmenting phasic and tonic GABAergic inhibition [<xref rid="B16-molecules-23-01061" ref-type="bibr">16</xref>]. </p></sec><sec id="sec3dot2dot2-molecules-23-01061"><title>3.2.2. Terpenes with Other Pharmacological Properties</title><p>&#x003b2;-Citronellol is an alcoholic monoterpene found in EOs such as <italic>Cymbopogon citrates</italic>, a plant with antihypertensive properties. Vasconcelos et al. [<xref rid="B76-molecules-23-01061" ref-type="bibr">76</xref>] assessed its pharmacological effects on the contractility of rat trachea. &#x003b2;-Citronellol exerted inhibitory effects on rat tracheal rings, with predominant effects on contractions that increased Ca<sup>2+</sup> inflow towards the cytosol by voltage-gated pathways [<xref rid="B76-molecules-23-01061" ref-type="bibr">76</xref>]. &#x003b2;-Citronellol antagonized transmembrane Ca<sup>2+</sup> influx from the extracellular milieu to produce myorelaxant actions [<xref rid="B76-molecules-23-01061" ref-type="bibr">76</xref>].</p></sec><sec id="sec3dot2dot3-molecules-23-01061"><title>3.2.3. Non-Terpene Constituents with Anticonvulsant, Anxiolytic Properties, and Their Underlying Mechanisms</title><p>Alpha(&#x003b1;)-asarone (<xref ref-type="fig" rid="molecules-23-01061-f005">Figure 5</xref>), a major effective component isolated from the Chinese medicinal herb <italic>Acorus tatarinowii</italic>, is clinically used as a medication for treating epilepsy, cough, bronchitis, and asthma. Huang et al. [<xref rid="B54-molecules-23-01061" ref-type="bibr">54</xref>] evaluated the action of &#x003b1;-asarone on the excitability of rat hippocampal neurons in culture and on the epileptic activity induced by pentylenetetrazole or kainite injection in vivo. They found that &#x003b1;-asarone inhibits the activity of hippocampal neurons and produces an antiepileptic effect in the central nervous system through enhancing tonic GABAergic inhibition [<xref rid="B54-molecules-23-01061" ref-type="bibr">54</xref>]. Using whole-cell patch-clamp recording, &#x003b1;-asarone was reported to inhibit the spontaneous firing of output neurons, mitral cells, in a mouse olfactory bulb brain slice preparation [<xref rid="B4-molecules-23-01061" ref-type="bibr">4</xref>]. </p><p>It was reported that &#x003b1;-asarone alleviates epilepsy by modulating GABA<sub>A</sub> receptors and inhibiting neuronal Na<sup>+</sup> channels [<xref rid="B4-molecules-23-01061" ref-type="bibr">4</xref>,<xref rid="B54-molecules-23-01061" ref-type="bibr">54</xref>]. While many other compounds like borneol were reported to act as positive allosteric GABA<sub>A</sub> receptor agonists to exert anxiolytic-like effects [<xref rid="B14-molecules-23-01061" ref-type="bibr">14</xref>,<xref rid="B16-molecules-23-01061" ref-type="bibr">16</xref>,<xref rid="B102-molecules-23-01061" ref-type="bibr">102</xref>], recent studies demonstrated that &#x003b1;-asarone acted as both a positive allesteric GABA<sub>A</sub> receptor agonist as well as a neuronal Na<sup>+</sup> channel blocker [<xref rid="B4-molecules-23-01061" ref-type="bibr">4</xref>,<xref rid="B5-molecules-23-01061" ref-type="bibr">5</xref>]. </p><p>The compound 1-Nitro-2-phenylethane (<xref ref-type="fig" rid="molecules-23-01061-f005">Figure 5</xref>) is the first nitro compound isolated from plants and is thought to be responsible for the plant&#x02019;s cinnamon scent [<xref rid="B67-molecules-23-01061" ref-type="bibr">67</xref>]. It is the main constituent of the EO of <italic>Aniba canelilla</italic> [<xref rid="B67-molecules-23-01061" ref-type="bibr">67</xref>]. The mechanisms underlying the vasorelaxant effects of the EO of <italic>Aniba canelilla</italic> (EOAC) and its main constituent 1-nitro-2-phenylethane (NP) were investigated in the isolated superior mesenteric artery from spontaneously hypertensive rats (SHRs) [<xref rid="B68-molecules-23-01061" ref-type="bibr">68</xref>]. Both EOAC and NP relaxed the contraction evoked by phorbol dibutyrate. Thus, it appears that NP is the active principal component of EOAC [<xref rid="B67-molecules-23-01061" ref-type="bibr">67</xref>,<xref rid="B68-molecules-23-01061" ref-type="bibr">68</xref>]. The vasorelaxation appears to be mediated through the inhibition of contractile events that are independent of Ca<sup>2+</sup> influx from the extracellular milieu [<xref rid="B67-molecules-23-01061" ref-type="bibr">67</xref>]. </p><p>The EO of <italic>Dennettia tripetala</italic> G. Baker (Annonaceae) demonstrated significant analgesic, anti-inflammatory, hypothermic, sedative, muscle relaxant, and central nervous system depressant activities [<xref rid="B115-molecules-23-01061" ref-type="bibr">115</xref>]. The EO of <italic>D. tripetala</italic> contains several compounds including 1-nitro-2-phenylethane (80%), &#x003b2;-eudesmol andnerolidol (4%), 1-linalool (11%), &#x003b2;-caryophyllene, and &#x003b2;-humuline. The compound 1-Nitro-2-phenylethane obtained from the oil of <italic>D. tripetala</italic> exhibited dose-dependent hypnotic, anticonvulsant and anxiolytic effects, and is the compound largely responsible for the neuropharmacological effects of the oil [<xref rid="B66-molecules-23-01061" ref-type="bibr">66</xref>].</p></sec></sec><sec id="sec3dot3-molecules-23-01061"><title>3.3. Terpenes with Convulsive Activities Acting as GABA<sub>A</sub> Receptor Antagonists </title><p>Most components of EOs act as GABA receptor agonists. Only a few compounds from EOs have been demonstrated to be GABA<sub>A</sub> receptor antagonists. Thujone (<xref ref-type="fig" rid="molecules-23-01061-f006">Figure 6</xref>), a cyclic monoterpenic ketone, is an active ingredient of wormwood oil and some other herbal medicines [<xref rid="B91-molecules-23-01061" ref-type="bibr">91</xref>,<xref rid="B116-molecules-23-01061" ref-type="bibr">116</xref>]. It is known that thujone is specifically a GABA<sub>A</sub> receptor antagonist and, by inhibiting GABA receptor activation, may make neurons fire more easily, causing muscle spasms and convulsions [<xref rid="B116-molecules-23-01061" ref-type="bibr">116</xref>,<xref rid="B117-molecules-23-01061" ref-type="bibr">117</xref>]. Dihydrocarvone (<xref ref-type="fig" rid="molecules-23-01061-f006">Figure 6</xref>) is present in oils of the caraway plant and is used for its fragrance as flavoring and for medicinal purposes. Dihydrocarvone was recently found to act as a negative allosteric modulator of this receptor [<xref rid="B91-molecules-23-01061" ref-type="bibr">91</xref>].</p></sec></sec><sec id="sec4-molecules-23-01061"><title>4. Conclusions</title><p>Based on the findings discussed above, it is clear that natural EOs demonstrate many neuro-pharmacological properties, such as anti-nociceptive, anti-inflammatory, anxiolytic, anti-depressive, and sedative properties. An increasing number of studies show that two inhibitory systems, the GABAergic system and the neuronal voltage-gated Na<sup>+</sup> channels, are most likely involved in such pharmacological effects. EOs are emerging as a promising source for modulation of the GABAergic system and Na<sup>+</sup> channels. The neuro-pharmacological activities and the underlying mechanisms of many constituents obtained from EOs have been reviewed. Most of the above-mentioned constituents are reported to have either anti-nociceptive or anxiolytic effects through activating the GABAergic system and by inhibiting neuronal Na<sup>+</sup> channels. Only a few constituents have been reported to antagonize GABA receptors. The perspective compounds targeting the GABAergic system and/or voltage-gated Na<sup>+</sup> channels could serve as better candidates or pharmacophores during new drug development to control pain and anxiety syndromes. </p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by grants from Latham Trust Fund, NIH (MD007597) and NSF (IOS-1355034) to TH.</p></ack><notes><title>Author Contributions</title><p>Z.-J.W. and T.H. wrote and reviewed the paper.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-23-01061"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y.L.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Tsang</surname><given-names>H.W.</given-names></name><name><surname>Leung</surname><given-names>A.Y.</given-names></name><name><surname>Cheung</surname><given-names>W.M.</given-names></name></person-group><article-title>A systematic review on the anxiolytic effects of aromatherapy in people with anxiety symptoms</article-title><source>J. Altern. Complement. Med.</source><year>2011</year><volume>17</volume><fpage>101</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1089/acm.2009.0277</pub-id><?supplied-pmid 21309711?><pub-id pub-id-type="pmid">21309711</pub-id></element-citation></ref><ref id="B2-molecules-23-01061"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tankam</surname><given-names>J.M.</given-names></name><name><surname>Ito</surname><given-names>M.</given-names></name></person-group><article-title>Inhalation of the essential oil of Piper guineense from Cameroon shows sedative and anxiolytic-like effects in mice</article-title><source>Biol. Pharm. Bull.</source><year>2013</year><volume>36</volume><fpage>1608</fpage><lpage>1614</lpage><pub-id pub-id-type="doi">10.1248/bpb.b13-00491</pub-id><?supplied-pmid 24088255?><pub-id pub-id-type="pmid">24088255</pub-id></element-citation></ref><ref id="B3-molecules-23-01061"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regnault-Roger</surname><given-names>C.</given-names></name><name><surname>Vincent</surname><given-names>C.</given-names></name><name><surname>Arnason</surname><given-names>J.T.</given-names></name></person-group><article-title>Essential oils in insect control: low-risk products in a high-stakes world</article-title><source>Annu. Rev. Entomol.</source><year>2012</year><volume>57</volume><fpage>405</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1146/annurev-ento-120710-100554</pub-id><?supplied-pmid 21942843?><pub-id pub-id-type="pmid">21942843</pub-id></element-citation></ref><ref id="B4-molecules-23-01061"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.J.</given-names></name><name><surname>Levinson</surname><given-names>S.R.</given-names></name><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Heinbockel</surname><given-names>T.</given-names></name></person-group><article-title>Identification of both GABAA receptors and voltage-activated Na(+) channels as molecular targets of anticonvulsant &#x003b1;-asarone</article-title><source>Front. Pharmacol.</source><year>2014</year><volume>5</volume><fpage>40</fpage><pub-id pub-id-type="doi">10.3389/fphar.2014.00040</pub-id><?supplied-pmid 24653701?><pub-id pub-id-type="pmid">24653701</pub-id></element-citation></ref><ref id="B5-molecules-23-01061"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.J.</given-names></name><name><surname>Tabakoff</surname><given-names>B.</given-names></name><name><surname>Levinson</surname><given-names>S.R.</given-names></name><name><surname>Heinbockel</surname><given-names>T.</given-names></name></person-group><article-title>Inhibition of Nav1.7 channels by methyl eugenol as a mechanism underlying its antinociceptive and anesthetic actions</article-title><source>Acta. Pharmacol. Sin.</source><year>2015</year><volume>36</volume><fpage>791</fpage><lpage>799</lpage><pub-id pub-id-type="doi">10.1038/aps.2015.26</pub-id><?supplied-pmid 26051112?><pub-id pub-id-type="pmid">26051112</pub-id></element-citation></ref><ref id="B6-molecules-23-01061"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semyanov</surname><given-names>A.</given-names></name><name><surname>Walker</surname><given-names>M.C.</given-names></name><name><surname>Kullmann</surname><given-names>D.M.</given-names></name><name><surname>Silver</surname><given-names>R.A.</given-names></name></person-group><article-title>Tonically active GABA A receptors: Modulating gain and maintaining the tone</article-title><source>Trends Neurosci.</source><year>2004</year><volume>27</volume><fpage>262</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2004.03.005</pub-id><?supplied-pmid 15111008?><pub-id pub-id-type="pmid">15111008</pub-id></element-citation></ref><ref id="B7-molecules-23-01061"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>A.A.</given-names></name><name><surname>Elliott</surname><given-names>J.R.</given-names></name></person-group><article-title>Characterization of TTX-sensitive and TTX-resistant sodium currents in small cells from adult rat dorsal root ganglia</article-title><source>J. Physiol.</source><year>1993</year><volume>463</volume><fpage>39</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1993.sp019583</pub-id><?supplied-pmid 8246189?><pub-id pub-id-type="pmid">8246189</pub-id></element-citation></ref><ref id="B8-molecules-23-01061"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toledo-Aral</surname><given-names>J.J.</given-names></name><name><surname>Moss</surname><given-names>B.L.</given-names></name><name><surname>He</surname><given-names>Z.J.</given-names></name><name><surname>Koszowski</surname><given-names>A.G.</given-names></name><name><surname>Whisenand</surname><given-names>T.</given-names></name><name><surname>Levinson</surname><given-names>S.R.</given-names></name><name><surname>Wolf</surname><given-names>J.J.</given-names></name><name><surname>Silos-Santiago</surname><given-names>I.</given-names></name><name><surname>Halegoua</surname><given-names>S.</given-names></name><name><surname>Mandel</surname><given-names>G.</given-names></name></person-group><article-title>Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1997</year><volume>94</volume><fpage>1527</fpage><lpage>1532</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.4.1527</pub-id><?supplied-pmid 9037087?><pub-id pub-id-type="pmid">9037087</pub-id></element-citation></ref><ref id="B9-molecules-23-01061"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>J.A.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Tanak</surname><given-names>M.</given-names></name><name><surname>Cumminsc</surname><given-names>T.R.</given-names></name><name><surname>Waxman</surname><given-names>S.G.</given-names></name></person-group><article-title>Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain</article-title><source>Pain</source><year>2004</year><volume>108</volume><fpage>237</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2003.12.035</pub-id><?supplied-pmid 15030943?><pub-id pub-id-type="pmid">15030943</pub-id></element-citation></ref><ref id="B10-molecules-23-01061"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nassar</surname><given-names>M.A.</given-names></name><name><surname>Stirling</surname><given-names>L.C.</given-names></name><name><surname>Forlani</surname><given-names>G.</given-names></name><name><surname>Baker</surname><given-names>M.D.</given-names></name><name><surname>Matthews</surname><given-names>E.A.</given-names></name><name><surname>Dickenson</surname><given-names>A.H.</given-names></name><name><surname>Wood</surname><given-names>J.N.</given-names></name></person-group><article-title>Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2004</year><volume>101</volume><fpage>12706</fpage><lpage>12711</lpage><pub-id pub-id-type="doi">10.1073/pnas.0404915101</pub-id><?supplied-pmid 15314237?><pub-id pub-id-type="pmid">15314237</pub-id></element-citation></ref><ref id="B11-molecules-23-01061"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>J.J.</given-names></name><name><surname>Reimann</surname><given-names>F.</given-names></name><name><surname>Nicholas</surname><given-names>A.K.</given-names></name><name><surname>Thornton</surname><given-names>G.</given-names></name><name><surname>Roberts</surname><given-names>E.</given-names></name><name><surname>Springell</surname><given-names>K.</given-names></name><name><surname>Karbani</surname><given-names>G.</given-names></name><name><surname>Jafri</surname><given-names>H.</given-names></name><name><surname>Mannan</surname><given-names>J.</given-names></name><name><surname>Raashid</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>An SCN9A channelopathy causes congenital inability to experience pain</article-title><source>Nature</source><year>2006</year><volume>444</volume><fpage>894</fpage><lpage>898</lpage><pub-id pub-id-type="doi">10.1038/nature05413</pub-id><?supplied-pmid 17167479?><pub-id pub-id-type="pmid">17167479</pub-id></element-citation></ref><ref id="B12-molecules-23-01061"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>S.</given-names></name><name><surname>Dahllund</surname><given-names>L.</given-names></name><name><surname>Eriksson</surname><given-names>A.B.</given-names></name><name><surname>Hellgren</surname><given-names>D.</given-names></name><name><surname>Karlsson</surname><given-names>U.</given-names></name><name><surname>Lund</surname><given-names>P.E.</given-names></name><name><surname>Meijer</surname><given-names>I.A.</given-names></name><name><surname>Meury</surname><given-names>L.</given-names></name><name><surname>Mills</surname><given-names>T.</given-names></name><name><surname>Moody</surname><given-names>A.</given-names></name><etal/></person-group><article-title>A stop codon mutation in SCN9A causes lack of pain sensation</article-title><source>Hum. Mol. Genet.</source><year>2007</year><volume>16</volume><fpage>2114</fpage><lpage>2121</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddm160</pub-id><?supplied-pmid 17597096?><pub-id pub-id-type="pmid">17597096</pub-id></element-citation></ref><ref id="B13-molecules-23-01061"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>C.A.</given-names></name><name><surname>Kohn</surname><given-names>D.O.</given-names></name><name><surname>de Lima</surname><given-names>V.M.</given-names></name><name><surname>Gargano</surname><given-names>A.C.</given-names></name><name><surname>Fl&#x000f3;rio</surname><given-names>J.C.</given-names></name><name><surname>Costa</surname><given-names>M.</given-names></name></person-group><article-title>The GABAergic system contributes to the anxiolytic-like effect of essential oil from <italic>Cymbopogon citratus</italic> (lemongrass)</article-title><source>J. Ethnopharmacol.</source><year>2011</year><volume>137</volume><fpage>828</fpage><lpage>836</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2011.07.003</pub-id><?supplied-pmid 21767622?><pub-id pub-id-type="pmid">21767622</pub-id></element-citation></ref><ref id="B14-molecules-23-01061"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granger</surname><given-names>R.E.</given-names></name><name><surname>Campbell</surname><given-names>E.L.</given-names></name><name><surname>Johnston</surname><given-names>G.A.</given-names></name></person-group><article-title>(+)- And (&#x02212;)-borneol: Efficacious positive modulators of GABA action at human recombinant alpha1beta2gamma2L GABA(A) receptors</article-title><source>Biochem. Pharmacol.</source><year>2005</year><volume>69</volume><fpage>1101</fpage><lpage>1111</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2005.01.002</pub-id><?supplied-pmid 15763546?><pub-id pub-id-type="pmid">15763546</pub-id></element-citation></ref><ref id="B15-molecules-23-01061"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname><given-names>B.S.</given-names></name><name><surname>Lee</surname><given-names>S.I.</given-names></name><name><surname>Ha</surname><given-names>J.H.</given-names></name><name><surname>Lee</surname><given-names>D.U.</given-names></name></person-group><article-title>Inhibitory effects of the essential oil from SuHeXiang Wan on the central nervous system after inhalation</article-title><source>Biol. Pharm. Bull.</source><year>2004</year><volume>27</volume><fpage>515</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1248/bpb.27.515</pub-id><?supplied-pmid 15056857?><pub-id pub-id-type="pmid">15056857</pub-id></element-citation></ref><ref id="B16-molecules-23-01061"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Brederode</surname><given-names>J.</given-names></name><name><surname>Atak</surname><given-names>S.</given-names></name><name><surname>Kessler</surname><given-names>A.</given-names></name><name><surname>Pischetsrieder</surname><given-names>M.</given-names></name><name><surname>Villmann</surname><given-names>C.</given-names></name><name><surname>Alzheimer</surname><given-names>C.</given-names></name></person-group><article-title>The terpenoids Myrtenol and Verbenol act on &#x003b4; subunit-containing GABAA receptors and enhance tonic inhibition in dentate gyrus granule cells</article-title><source>Neurosci. Lett.</source><year>2016</year><volume>628</volume><fpage>91</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2016.06.027</pub-id><?supplied-pmid 27312536?><pub-id pub-id-type="pmid">27312536</pub-id></element-citation></ref><ref id="B17-molecules-23-01061"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreira-Lobo</surname><given-names>D.C.</given-names></name><name><surname>Linhares-Siqueira</surname><given-names>E.D.</given-names></name><name><surname>Cruz</surname><given-names>G.M.</given-names></name><name><surname>Cruz</surname><given-names>J.S.</given-names></name><name><surname>Carvalho-de-Souza</surname><given-names>J.L.</given-names></name><name><surname>Lahlou</surname><given-names>S.</given-names></name><name><surname>Coelho-de-Souza</surname><given-names>A.N.</given-names></name><name><surname>Barbosa</surname><given-names>R.</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>P.J.</given-names></name><name><surname>Leal-Cardoso</surname><given-names>J.H.</given-names></name></person-group><article-title>Eugenol modifies the excitability of rat sciatic nerve and superior cervical ganglion neurons</article-title><source>Neurosci. Lett.</source><year>2010</year><volume>472</volume><fpage>220</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2010.02.009</pub-id><?supplied-pmid 20152883?><pub-id pub-id-type="pmid">20152883</pub-id></element-citation></ref><ref id="B18-molecules-23-01061"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manayi</surname><given-names>A.</given-names></name><name><surname>Nabavi</surname><given-names>S.M.</given-names></name><name><surname>Daglia</surname><given-names>M.</given-names></name><name><surname>Jafari</surname><given-names>S.</given-names></name></person-group><article-title>Natural terpenoids as a promising source for modulation of GABAergic system and treatment of neurological diseases</article-title><source>Pharmacol. Rep.</source><year>2016</year><volume>68</volume><fpage>671</fpage><lpage>679</lpage><pub-id pub-id-type="doi">10.1016/j.pharep.2016.03.014</pub-id><?supplied-pmid 27110875?><pub-id pub-id-type="pmid">27110875</pub-id></element-citation></ref><ref id="B19-molecules-23-01061"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majnooni</surname><given-names>M.B.</given-names></name><name><surname>Mohammadi-Farani</surname><given-names>A.</given-names></name><name><surname>Gholivand</surname><given-names>M.B.</given-names></name><name><surname>Nikbakht</surname><given-names>M.R.</given-names></name><name><surname>Bahrami</surname><given-names>G.R.</given-names></name></person-group><article-title>Chemical composition and anxiolytic evaluation of <italic>Achillea Wilhelmsii</italic> C. Koch essential oil in rat</article-title><source>Res. Pharm. Sci.</source><year>2013</year><volume>8</volume><fpage>269</fpage><lpage>275</lpage><?supplied-pmid 24082896?><pub-id pub-id-type="pmid">24082896</pub-id></element-citation></ref><ref id="B20-molecules-23-01061"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname><given-names>B.S.</given-names></name><name><surname>Park</surname><given-names>K.S.</given-names></name><name><surname>Ha</surname><given-names>J.H.</given-names></name><name><surname>Park</surname><given-names>J.H.</given-names></name><name><surname>Lim</surname><given-names>J.C.</given-names></name><name><surname>Lee</surname><given-names>D.U.</given-names></name></person-group><article-title>Inhibitory effects of the fragrance inhalation of essential oil from <italic>Acorus gramineus</italic> on central nervous system</article-title><source>Biol. Pharm. Bull.</source><year>2003</year><volume>26</volume><fpage>978</fpage><lpage>982</lpage><pub-id pub-id-type="doi">10.1248/bpb.26.978</pub-id><?supplied-pmid 12843622?><pub-id pub-id-type="pmid">12843622</pub-id></element-citation></ref><ref id="B21-molecules-23-01061"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abuhamdah</surname><given-names>S.</given-names></name><name><surname>Abuhamdah</surname><given-names>R.</given-names></name><name><surname>Howes</surname><given-names>M.J.</given-names></name><name><surname>Al-Olimat</surname><given-names>S.</given-names></name><name><surname>Ennaceur</surname><given-names>A.</given-names></name><name><surname>Chazot</surname><given-names>P.L.</given-names></name></person-group><article-title>Pharmacological and neuroprotective profile of an essential oil derived from leaves of <italic>Aloysia citrodora</italic> Palau</article-title><source>J. Pharm. Pharmacol.</source><year>2015</year><volume>67</volume><fpage>1306</fpage><lpage>1315</lpage><pub-id pub-id-type="doi">10.1111/jphp.12424</pub-id><?supplied-pmid 25877296?><pub-id pub-id-type="pmid">25877296</pub-id></element-citation></ref><ref id="B22-molecules-23-01061"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Darwish</surname><given-names>M.S.</given-names></name><name><surname>Cabral</surname><given-names>C.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>M.J.</given-names></name><name><surname>Cavaleiro</surname><given-names>C.</given-names></name><name><surname>Cruz</surname><given-names>M.T.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name><name><surname>Salgueiro</surname><given-names>L.</given-names></name></person-group><article-title><italic>Artemisia herba-alba</italic> essential oil from Buseirah (South Jordan): Chemical characterization and assessment of safe antifungal and anti-inflammatory doses</article-title><source>J. Ethnopharmacol.</source><year>2015</year><volume>174</volume><fpage>153</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2015.08.005</pub-id><?supplied-pmid 26277492?><pub-id pub-id-type="pmid">26277492</pub-id></element-citation></ref><ref id="B23-molecules-23-01061"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anaya-Eugenio</surname><given-names>G.D.</given-names></name><name><surname>Rivero-Cruz</surname><given-names>I.</given-names></name><name><surname>Bye</surname><given-names>R.</given-names></name><name><surname>Linares</surname><given-names>E.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name></person-group><article-title>Antinociceptive activity of the essential oil from <italic>Artemisia ludoviciana</italic></article-title><source>J. Ethnopharmacol.</source><year>2016</year><volume>179</volume><fpage>403</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2016.01.008</pub-id><?supplied-pmid 26792321?><pub-id pub-id-type="pmid">26792321</pub-id></element-citation></ref><ref id="B24-molecules-23-01061"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Darwish</surname><given-names>M.S.</given-names></name><name><surname>Cabral</surname><given-names>C.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>M.J.</given-names></name><name><surname>Cavaleiro</surname><given-names>C.</given-names></name><name><surname>Cruz</surname><given-names>M.T.</given-names></name><name><surname>Zulfiqar</surname><given-names>A.</given-names></name><name><surname>Khan</surname><given-names>I.A.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name><name><surname>Salgueiro</surname><given-names>L.</given-names></name></person-group><article-title>Chemical composition and biological activities of <italic>Artemisia judaica</italic> essential oil from southern desert of Jordan</article-title><source>J. Ethnopharmacol.</source><year>2016</year><volume>191</volume><fpage>161</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2016.06.023</pub-id><?supplied-pmid 27318275?><pub-id pub-id-type="pmid">27318275</pub-id></element-citation></ref><ref id="B25-molecules-23-01061"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maham</surname><given-names>M.</given-names></name><name><surname>Moslemzadeh</surname><given-names>H.</given-names></name><name><surname>Jalilzadeh-Amin</surname><given-names>G.</given-names></name></person-group><article-title>Antinociceptive effect of the essential oil of tarragon (<italic>Artemisia dracunculus</italic>)</article-title><source>Pharm. Biol.</source><year>2014</year><volume>52</volume><fpage>208</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.3109/13880209.2013.824007</pub-id><?supplied-pmid 24074293?><pub-id pub-id-type="pmid">24074293</pub-id></element-citation></ref><ref id="B26-molecules-23-01061"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>H.J.</given-names></name><name><surname>Lim</surname><given-names>E.J.</given-names></name><name><surname>Zhao</surname><given-names>R.J.</given-names></name><name><surname>Oh</surname><given-names>S.R.</given-names></name><name><surname>Jung</surname><given-names>J.W.</given-names></name><name><surname>Ahn</surname><given-names>E.M.</given-names></name><name><surname>Lee</surname><given-names>E.S.</given-names></name><name><surname>Koo</surname><given-names>J.S.</given-names></name><name><surname>Kim</surname><given-names>H.Y.</given-names></name><name><surname>Chang</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Effect of the fragrance inhalation of essential oil from <italic>Asarum heterotropoides</italic> on depression-like behaviors in mice</article-title><source>BMC Complement. Altern. Med.</source><year>2015</year><volume>15</volume><elocation-id>43</elocation-id><pub-id pub-id-type="doi">10.1186/s12906-015-0571-1</pub-id><?supplied-pmid 25881143?><pub-id pub-id-type="pmid">25881143</pub-id></element-citation></ref><ref id="B27-molecules-23-01061"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hossain</surname><given-names>S.J.</given-names></name><name><surname>Aoshima</surname><given-names>H.</given-names></name><name><surname>Koda</surname><given-names>H.</given-names></name><name><surname>Kiso</surname><given-names>Y.</given-names></name></person-group><article-title>Fragrances in oolong tea that enhance the response of GABAA receptors</article-title><source>Biosci. Biotechnol. Biochem.</source><year>2004</year><volume>68</volume><fpage>1842</fpage><lpage>1848</lpage><pub-id pub-id-type="doi">10.1271/bbb.68.1842</pub-id><?supplied-pmid 15388958?><pub-id pub-id-type="pmid">15388958</pub-id></element-citation></ref><ref id="B28-molecules-23-01061"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>C.A.</given-names></name><name><surname>Cury</surname><given-names>T.C.</given-names></name><name><surname>Cassettari</surname><given-names>B.O.</given-names></name><name><surname>Takahira</surname><given-names>R.K.</given-names></name><name><surname>Fl&#x000f3;rio</surname><given-names>J.C.</given-names></name><name><surname>Costa</surname><given-names>M.</given-names></name></person-group><article-title><italic>Citrus aurantium</italic> L. essential oil exhibits anxiolytic-like activity mediated by 5-HT(1A)-receptors and reduces cholesterol after repeated oral treatment</article-title><source>BMC Complement. Altern. Med.</source><year>2013</year><volume>13</volume><elocation-id>42</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-13-42</pub-id><?supplied-pmid 23432968?><pub-id pub-id-type="pmid">23432968</pub-id></element-citation></ref><ref id="B29-molecules-23-01061"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagetta</surname><given-names>G.</given-names></name><name><surname>Morrone</surname><given-names>L.A.</given-names></name><name><surname>Rombol&#x000e0;</surname><given-names>L.</given-names></name><name><surname>Amantea</surname><given-names>D.</given-names></name><name><surname>Russo</surname><given-names>R.</given-names></name><name><surname>Berliocchi</surname><given-names>L.</given-names></name><name><surname>Sakurada</surname><given-names>S.</given-names></name><name><surname>Sakurada</surname><given-names>T.</given-names></name><name><surname>Rotiroti</surname><given-names>D.</given-names></name><name><surname>Corasaniti</surname><given-names>M.T.</given-names></name></person-group><article-title>Neuropharmacology of the essential oil of bergamot</article-title><source>Fitoterapia</source><year>2010</year><volume>81</volume><fpage>453</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2010.01.013</pub-id><?supplied-pmid 20093169?><pub-id pub-id-type="pmid">20093169</pub-id></element-citation></ref><ref id="B30-molecules-23-01061"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faturi</surname><given-names>C.B.</given-names></name><name><surname>Leite</surname><given-names>J.R.</given-names></name><name><surname>Alves</surname><given-names>P.B.</given-names></name><name><surname>Canton</surname><given-names>A.C.</given-names></name><name><surname>Teixeira-Silva</surname><given-names>F.</given-names></name></person-group><article-title>Anxiolytic-like effect of sweet orange aroma in Wistar rats</article-title><source>Prog. Neuropsychopharmacol. Biol. Psychiatry</source><year>2010</year><volume>34</volume><fpage>605</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1016/j.pnpbp.2010.02.020</pub-id><?supplied-pmid 20211673?><pub-id pub-id-type="pmid">20211673</pub-id></element-citation></ref><ref id="B31-molecules-23-01061"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cioanca</surname><given-names>O.</given-names></name><name><surname>Hritcu</surname><given-names>L.</given-names></name><name><surname>Mihasan</surname><given-names>M.</given-names></name><name><surname>Trifan</surname><given-names>A.</given-names></name><name><surname>Hancianu</surname><given-names>M.</given-names></name></person-group><article-title>Inhalation of coriander volatile oil increased anxiolytic-antidepressant-like behaviors and decreased oxidative status in beta-amyloid (1&#x02013;42) rat model of Alzheimer&#x02019;s disease</article-title><source>Physiol. Behav.</source><year>2014</year><volume>131</volume><fpage>68</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.physbeh.2014.04.021</pub-id><?supplied-pmid 24747275?><pub-id pub-id-type="pmid">24747275</pub-id></element-citation></ref><ref id="B32-molecules-23-01061"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>M.R.</given-names></name><name><surname>Ximenes</surname><given-names>R.M.</given-names></name><name><surname>da Costa</surname><given-names>J.G.</given-names></name><name><surname>Leal</surname><given-names>L.K.</given-names></name><name><surname>de Lopes</surname><given-names>A.A.</given-names></name><name><surname>Viana</surname><given-names>G.S.</given-names></name></person-group><article-title>Comparative anticonvulsant activities of the essential oils (EOs) from <italic>Cymbopogon winterianus</italic> Jowitt and <italic>Cymbopogon citratus</italic> (DC) Stapf. in mice</article-title><source>Naunyn. Schmiedebergs. Arch. Pharmacol.</source><year>2010</year><volume>381</volume><fpage>415</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1007/s00210-010-0494-9</pub-id><?supplied-pmid 20237771?><pub-id pub-id-type="pmid">20237771</pub-id></element-citation></ref><ref id="B33-molecules-23-01061"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000e9;ciga-Campos</surname><given-names>M.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name><name><surname>Rivero-Cruz</surname><given-names>I.</given-names></name></person-group><article-title>Antinociceptive pharmacological profile of <italic>Dysphania graveolens</italic> in mouse</article-title><source>Biomed. Pharmacother.</source><year>2017</year><volume>89</volume><fpage>933</fpage><lpage>938</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2017.02.096</pub-id><?supplied-pmid 28292021?><pub-id pub-id-type="pmid">28292021</pub-id></element-citation></ref><ref id="B34-molecules-23-01061"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>L.L.</given-names></name><name><surname>Garlet</surname><given-names>Q.I.</given-names></name><name><surname>Benovit</surname><given-names>S.C.</given-names></name><name><surname>Dolci</surname><given-names>G.</given-names></name><name><surname>Mallmann</surname><given-names>C.A.</given-names></name><name><surname>B&#x000fc;rger</surname><given-names>M.E.</given-names></name><name><surname>Baldisserotto</surname><given-names>B.</given-names></name><name><surname>Longhi</surname><given-names>S.J.</given-names></name><name><surname>Heinzmann</surname><given-names>B.M.</given-names></name></person-group><article-title>Sedative and anesthetic activities of the essential oils of <italic>Hyptis mutabilis</italic> (Rich.) <italic>Briq.</italic> and their isolated components in silver catfish (<italic>Rhamdia quelen</italic>)</article-title><source>Braz. J. Med. Biol. Res.</source><year>2013</year><volume>46</volume><fpage>771</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1590/1414-431X20133013</pub-id><?supplied-pmid 24068193?><pub-id pub-id-type="pmid">24068193</pub-id></element-citation></ref><ref id="B35-molecules-23-01061"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chioca</surname><given-names>L.R.</given-names></name><name><surname>Ferro</surname><given-names>M.M.</given-names></name><name><surname>Baretta</surname><given-names>I.P.</given-names></name><name><surname>Oliveira</surname><given-names>S.M.</given-names></name><name><surname>Silva</surname><given-names>C.R.</given-names></name><name><surname>Ferreira</surname><given-names>J.</given-names></name><name><surname>Losso</surname><given-names>E.M.</given-names></name><name><surname>Andreatini</surname><given-names>R.</given-names></name></person-group><article-title>Anxiolytic-like effect of lavender essential oil inhalation in mice: Participation of serotonergic but not GABAA/benzodiazepine neurotransmission</article-title><source>J. Ethnopharmacol.</source><year>2013</year><volume>147</volume><fpage>412</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2013.03.028</pub-id><?supplied-pmid 23524167?><pub-id pub-id-type="pmid">23524167</pub-id></element-citation></ref><ref id="B36-molecules-23-01061"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heldwein</surname><given-names>C.G.</given-names></name><name><surname>Silva</surname><given-names>L.L.</given-names></name><name><surname>Reckziegel</surname><given-names>P.</given-names></name><name><surname>Barros</surname><given-names>F.M.</given-names></name><name><surname>B&#x000fc;rger</surname><given-names>M.E.</given-names></name><name><surname>Baldisserotto</surname><given-names>B.</given-names></name><name><surname>Mallmann</surname><given-names>C.A.</given-names></name><name><surname>Schmidt</surname><given-names>D.</given-names></name><name><surname>Caron</surname><given-names>B.O.</given-names></name><name><surname>Heinzmann</surname><given-names>B.M.</given-names></name></person-group><article-title>Participation of the GABAergic system in the anesthetic effect of <italic>Lippia alba</italic> (Mill.) N.E. Brown essential oil</article-title><source>Braz. J. Med. Biol. Res.</source><year>2012</year><volume>45</volume><fpage>436</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1590/S0100-879X2012007500052</pub-id><?supplied-pmid 22473320?><pub-id pub-id-type="pmid">22473320</pub-id></element-citation></ref><ref id="B37-molecules-23-01061"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komiya</surname><given-names>M.</given-names></name><name><surname>Takeuchi</surname><given-names>T.</given-names></name><name><surname>Harada</surname><given-names>E.</given-names></name></person-group><article-title>Lemon oil vapor causes an anti-stress effect via modulating the 5-HT and DA activities in mice</article-title><source>Behav. Brain Res.</source><year>2006</year><volume>172</volume><fpage>240</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1016/j.bbr.2006.05.006</pub-id><?supplied-pmid 16780969?><pub-id pub-id-type="pmid">16780969</pub-id></element-citation></ref><ref id="B38-molecules-23-01061"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abuhamdah</surname><given-names>S.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Elliott</surname><given-names>M.S.</given-names></name><name><surname>Howes</surname><given-names>M.J.</given-names></name><name><surname>Ballard</surname><given-names>C.</given-names></name><name><surname>Holmes</surname><given-names>C.</given-names></name><name><surname>Burns</surname><given-names>A.</given-names></name><name><surname>Perry</surname><given-names>E.K.</given-names></name><name><surname>Francis</surname><given-names>P.T.</given-names></name><name><surname>Lees</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Pharmacological profile of an essential oil derived from Melissa officinalis with anti-agitation properties: Focus on ligand-gated channels</article-title><source>J. Pharm. Pharmacol.</source><year>2008</year><volume>60</volume><fpage>377</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1211/jpp.60.3.0014</pub-id><?supplied-pmid 18284819?><pub-id pub-id-type="pmid">18284819</pub-id></element-citation></ref><ref id="B39-molecules-23-01061"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raza</surname><given-names>M.</given-names></name><name><surname>Alghasham</surname><given-names>A.A.</given-names></name><name><surname>Alorainy</surname><given-names>M.S.</given-names></name><name><surname>El-Hadiyah</surname><given-names>T.M.</given-names></name></person-group><article-title>Potentiation of Valproate-induced Anticonvulsant Response by Nigella sativa Seed Constituents: The Role of GABA Receptors</article-title><source>Int. J. Health Sci.</source><year>2008</year><volume>2</volume><fpage>15</fpage><lpage>25</lpage></element-citation></ref><ref id="B40-molecules-23-01061"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoshima</surname><given-names>H.</given-names></name><name><surname>Hamamoto</surname><given-names>K.</given-names></name></person-group><article-title>Potentiation of GABAA receptors expressed in <italic>Xenopus oocytes</italic> by perfume and phytoncid</article-title><source>Biosci. Biotechnol. Biochem.</source><year>1999</year><volume>63</volume><fpage>743</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1271/bbb.63.743</pub-id><?supplied-pmid 10361687?><pub-id pub-id-type="pmid">10361687</pub-id></element-citation></ref><ref id="B41-molecules-23-01061"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirole</surname><given-names>R.L.</given-names></name><name><surname>Shirole</surname><given-names>N.L.</given-names></name><name><surname>Saraf</surname><given-names>M.N.</given-names></name></person-group><article-title>In vitro relaxant and spasmolytic effects of essential oil of <italic>Pistacia integerrima</italic> Stewart ex Brandis Galls</article-title><source>J. Ethnopharmacol.</source><year>2015</year><volume>168</volume><fpage>61</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2015.02.001</pub-id><?supplied-pmid 25732838?><pub-id pub-id-type="pmid">25732838</pub-id></element-citation></ref><ref id="B42-molecules-23-01061"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seol</surname><given-names>G.H.</given-names></name><name><surname>Shim</surname><given-names>H.S.</given-names></name><name><surname>Kim</surname><given-names>P.J.</given-names></name><name><surname>Moon</surname><given-names>H.K.</given-names></name><name><surname>Lee</surname><given-names>K.H.</given-names></name><name><surname>Shim</surname><given-names>I.</given-names></name><name><surname>Suh</surname><given-names>S.H.</given-names></name><name><surname>Min</surname><given-names>S.S.</given-names></name></person-group><article-title>Antidepressant-like effect of <italic>Salvia sclarea</italic> is explained by modulation of dopamine activities in rats</article-title><source>J. Ethnopharmacol.</source><year>2010</year><volume>130</volume><fpage>187</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2010.04.035</pub-id><?supplied-pmid 20441789?><pub-id pub-id-type="pmid">20441789</pub-id></element-citation></ref><ref id="B43-molecules-23-01061"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C.W.</given-names></name><name><surname>Chow</surname><given-names>J.C.</given-names></name><name><surname>Tsai</surname><given-names>J.J.</given-names></name><name><surname>Wu</surname><given-names>S.N.</given-names></name></person-group><article-title>Characterizing the effects of Eugenol on neuronal ionic currents and hyperexcitability</article-title><source>Psychopharmacology</source><year>2012</year><volume>221</volume><fpage>575</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1007/s00213-011-2603-y</pub-id><?supplied-pmid 22160139?><pub-id pub-id-type="pmid">22160139</pub-id></element-citation></ref><ref id="B44-molecules-23-01061"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin</surname><given-names>R.H.</given-names></name><name><surname>Garcia</surname><given-names>D.A.</given-names></name><name><surname>Martijena</surname><given-names>I.D.</given-names></name><name><surname>Zygadlo</surname><given-names>J.A.</given-names></name><name><surname>Arce</surname><given-names>A.</given-names></name><name><surname>Perillo</surname><given-names>M.A.</given-names></name></person-group><article-title>Anxiogenic-like effects of <italic>Tagetes minuta</italic> L essential oil on T-maze and tonic immobility behaviour in domestic chicks</article-title><source>Fundam. Clin. Pharmacol.</source><year>1998</year><volume>12</volume><fpage>426</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1111/j.1472-8206.1998.tb00967.x</pub-id><?supplied-pmid 9711465?><pub-id pub-id-type="pmid">9711465</pub-id></element-citation></ref><ref id="B45-molecules-23-01061"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gon&#x000e7;alves</surname><given-names>J.C.</given-names></name><name><surname>de Meneses</surname><given-names>D.A.</given-names></name><name><surname>de Vasconcelos</surname><given-names>A.P.</given-names></name><name><surname>Piauilino</surname><given-names>C.A.</given-names></name><name><surname>Almeida</surname><given-names>F.R.</given-names></name><name><surname>Napoli</surname><given-names>E.M.</given-names></name><name><surname>Ruberto</surname><given-names>G.</given-names></name><name><surname>de Ara&#x000fa;jo</surname><given-names>D.A.</given-names></name></person-group><article-title>Essential oil composition and antinociceptive activity of <italic>Thymus capitatus</italic></article-title><source>Pharm. Biol.</source><year>2017</year><volume>55</volume><fpage>782</fpage><lpage>786</lpage><pub-id pub-id-type="doi">10.1080/13880209.2017.1279672</pub-id><?supplied-pmid 28103733?><pub-id pub-id-type="pmid">28103733</pub-id></element-citation></ref><ref id="B46-molecules-23-01061"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houghton</surname><given-names>P.J.</given-names></name></person-group><article-title>The scientific basis for the reputed activity of Valerian</article-title><source>J. Pharm. Pharmacol.</source><year>1999</year><volume>51</volume><fpage>505</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1211/0022357991772772</pub-id><?supplied-pmid 10411208?><pub-id pub-id-type="pmid">10411208</pub-id></element-citation></ref><ref id="B47-molecules-23-01061"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakurada</surname><given-names>T.</given-names></name><name><surname>Kuwahata</surname><given-names>H.</given-names></name><name><surname>Katsuyama</surname><given-names>H.</given-names></name><name><surname>Katsuyama</surname><given-names>S.</given-names></name><name><surname>Komatsu</surname><given-names>T.</given-names></name><name><surname>Morrone</surname><given-names>L.A.</given-names></name></person-group><article-title>Intraplantar injection of bergamot essential oil into the mouse hindpaw: Effects on capsaicin-induced nociceptive behaviors</article-title><source>Int. Rev. Neurobiol.</source><year>2009</year><volume>85</volume><fpage>235</fpage><lpage>246</lpage></element-citation></ref><ref id="B48-molecules-23-01061"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viana</surname><given-names>G.S.B.</given-names></name><name><surname>Vale</surname><given-names>T.G.</given-names></name><name><surname>Pinho</surname><given-names>R.S.N.</given-names></name><name><surname>Matos</surname><given-names>F.J.A.</given-names></name></person-group><article-title>Antinociceptive effect of the essential oil from <italic>Cymbopogon citratus</italic> in mice</article-title><source>J. Ethnopharmacol.</source><year>2000</year><volume>70</volume><fpage>323</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(99)00168-3</pub-id><pub-id pub-id-type="pmid">10837994</pub-id></element-citation></ref><ref id="B49-molecules-23-01061"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umezu</surname><given-names>T.</given-names></name></person-group><article-title>Anticonflict effects of plant-derived essential oils</article-title><source>Pharmacol. Biochem. Behav.</source><year>1999</year><volume>64</volume><fpage>35</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/S0091-3057(99)00115-X</pub-id><pub-id pub-id-type="pmid">10494995</pub-id></element-citation></ref><ref id="B50-molecules-23-01061"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tortoriello</surname><given-names>J.</given-names></name><name><surname>Romero</surname><given-names>O.</given-names></name></person-group><article-title>Plants used by Mexican traditional medicine with presumable sedative properties: An ethnobotanical approach</article-title><source>Arch. Med. Res.</source><year>1992</year><volume>23</volume><fpage>111</fpage><lpage>116</lpage><?supplied-pmid 1308799?><pub-id pub-id-type="pmid">1308799</pub-id></element-citation></ref><ref id="B51-molecules-23-01061"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco</surname><given-names>M.M.</given-names></name><name><surname>Costa</surname><given-names>C.A.R.A.</given-names></name><name><surname>Freire</surname><given-names>A.O.</given-names></name><name><surname>Santos</surname><given-names>J.G.</given-names><suffix>Jr.</suffix></name><name><surname>Costa</surname><given-names>M.</given-names></name></person-group><article-title>Neurobehavioral effect of essential oil of Cymbopogon citratus in mice</article-title><source>Phytomedicine</source><year>2009</year><volume>16</volume><fpage>265</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2007.04.007</pub-id><?supplied-pmid 17561386?><pub-id pub-id-type="pmid">17561386</pub-id></element-citation></ref><ref id="B52-molecules-23-01061"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bidinotto</surname><given-names>L.T.</given-names></name><name><surname>Costa</surname><given-names>C.A.</given-names></name><name><surname>Salvadori</surname><given-names>D.M.</given-names></name><name><surname>Costa</surname><given-names>M.</given-names></name><name><surname>Rodrigues</surname><given-names>M.A.</given-names></name><name><surname>Barbisan</surname><given-names>L.F.</given-names></name></person-group><article-title>Protective effects of lemongrass (<italic>Cymbopogon citratus</italic> STAPF) essential oil on DNA damage and carcinogenesis in female Balb/C mice</article-title><source>J. Appl. Toxicol.</source><year>2011</year><volume>31</volume><fpage>536</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1002/jat.1593</pub-id><?supplied-pmid 21089157?><pub-id pub-id-type="pmid">21089157</pub-id></element-citation></ref><ref id="B53-molecules-23-01061"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drew</surname><given-names>A.K.</given-names></name><name><surname>Whyte</surname><given-names>I.M.</given-names></name><name><surname>Bensoussan</surname><given-names>A.</given-names></name><name><surname>Dawson</surname><given-names>A.H.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Myers</surname><given-names>S.P.</given-names></name></person-group><article-title>Chinese herbal medicine toxicology database: Monograph on Herba Asari, &#x0201c;xi xin&#x0201d;</article-title><source>J. Toxicol. Clin. Toxicol.</source><year>2002</year><volume>40</volume><fpage>169</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1081/CLT-120004405</pub-id><?supplied-pmid 12126188?><pub-id pub-id-type="pmid">12126188</pub-id></element-citation></ref><ref id="B54-molecules-23-01061"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>W.G.</given-names></name><name><surname>Zhang</surname><given-names>X.B.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>T.L.</given-names></name><name><surname>Wu</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group><article-title>Alpha-asarone from <italic>Acorus gramineus</italic> alleviates epilepsy by modulating A-type GABA receptors</article-title><source>Neuropharmacology</source><year>2013</year><volume>65</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2012.09.001</pub-id><?supplied-pmid 22975146?><pub-id pub-id-type="pmid">22975146</pub-id></element-citation></ref><ref id="B55-molecules-23-01061"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Cao</surname><given-names>C.</given-names></name><name><surname>Shang</surname><given-names>M.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Ye</surname><given-names>J.</given-names></name><name><surname>Cai</surname><given-names>S.</given-names></name></person-group><article-title>Assessment on anti-nociception and anti-inflammation pharmacodynamics of <italic>Asarum heterotropoides</italic> var. mandshuricum and <italic>Asarum sieboldii</italic></article-title><source>Zhongguo Zhong Yao Za Zhi</source><year>2012</year><volume>37</volume><fpage>625</fpage><lpage>631</lpage><?supplied-pmid 22693907?><pub-id pub-id-type="pmid">22693907</pub-id></element-citation></ref><ref id="B56-molecules-23-01061"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vale</surname><given-names>T.G.</given-names></name><name><surname>Matos</surname><given-names>F.J.</given-names></name><name><surname>de Lima</surname><given-names>T.C.</given-names></name><name><surname>Viana</surname><given-names>G.S.</given-names></name></person-group><article-title>Behavioral effects of essential oils from <italic>Lippia alba</italic> (Mill.) N.E. Brown chemotypes</article-title><source>J. Ethnopharmacol.</source><year>1999</year><volume>67</volume><fpage>127</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(98)00215-3</pub-id><pub-id pub-id-type="pmid">10619375</pub-id></element-citation></ref><ref id="B57-molecules-23-01061"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Do Vale</surname><given-names>T.G.</given-names></name><name><surname>Furtado</surname><given-names>E.C.</given-names></name><name><surname>Santos</surname><given-names>J.G.</given-names><suffix>Jr.</suffix></name><name><surname>Viana</surname><given-names>G.S.</given-names></name></person-group><article-title>Central effects of citral, myrcene and limonene, constituents of essential oil chemotypes from <italic>Lippia alba</italic> (Mill.) n.e. Brown</article-title><source>Phytomedicine</source><year>2002</year><volume>9</volume><fpage>709</fpage><lpage>714</lpage><pub-id pub-id-type="doi">10.1078/094471102321621304</pub-id><?supplied-pmid 12587690?><pub-id pub-id-type="pmid">12587690</pub-id></element-citation></ref><ref id="B58-molecules-23-01061"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatano</surname><given-names>V.Y.</given-names></name><name><surname>Torricelli</surname><given-names>A.S.</given-names></name><name><surname>Giassi</surname><given-names>A.C.</given-names></name><name><surname>Coslope</surname><given-names>L.A.</given-names></name><name><surname>Viana</surname><given-names>M.B.</given-names></name></person-group><article-title>Anxiolytic effects of repeated treatment with an essential oil from <italic>Lippia alba</italic> and (R)-(&#x02212;)-carvone in the elevated T-maze</article-title><source>Braz. J. Med. Biol. Res.</source><year>2012</year><volume>45</volume><fpage>238</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1590/S0100-879X2012007500021</pub-id><?supplied-pmid 22358424?><pub-id pub-id-type="pmid">22358424</pub-id></element-citation></ref><ref id="B59-molecules-23-01061"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kritsidima</surname><given-names>M.</given-names></name><name><surname>Newton</surname><given-names>T.</given-names></name><name><surname>Asimakopoulou</surname><given-names>K.</given-names></name></person-group><article-title>The effects of lavender scent on dental patient anxiety levels: A cluster randomised-controlled trial</article-title><source>Commun. Dent. Oral. Epidemiol.</source><year>2010</year><volume>38</volume><fpage>83</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0528.2009.00511.x</pub-id><?supplied-pmid 19968674?><pub-id pub-id-type="pmid">19968674</pub-id></element-citation></ref><ref id="B60-molecules-23-01061"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>M.</given-names></name><name><surname>Satou</surname><given-names>T.</given-names></name><name><surname>Ohashi</surname><given-names>M.</given-names></name><name><surname>Hayashi</surname><given-names>S.</given-names></name><name><surname>Sadamoto</surname><given-names>K.</given-names></name><name><surname>Koike</surname><given-names>K.</given-names></name></person-group><article-title>Interspecies comparison of chemical composition and anxiolytic-like effects of lavender oils upon inhalation</article-title><source>Nat. Prod. Commun.</source><year>2011</year><volume>6</volume><fpage>1769</fpage><lpage>1774</lpage><?supplied-pmid 22224307?><pub-id pub-id-type="pmid">22224307</pub-id></element-citation></ref><ref id="B61-molecules-23-01061"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woronuk</surname><given-names>G.</given-names></name><name><surname>Demissie</surname><given-names>Z.</given-names></name><name><surname>Rheault</surname><given-names>M.</given-names></name><name><surname>Mahmoud</surname><given-names>S.</given-names></name></person-group><article-title>Biosynthesis and therapeutic properties of <italic>Lavandula</italic> essential oil constituents</article-title><source>Planta Medica</source><year>2011</year><volume>77</volume><fpage>7</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1055/s-0030-1250136</pub-id><?supplied-pmid 20665367?><pub-id pub-id-type="pmid">20665367</pub-id></element-citation></ref><ref id="B62-molecules-23-01061"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linck</surname><given-names>V.M.</given-names></name><name><surname>da Silva</surname><given-names>A.L.</given-names></name><name><surname>Figueir&#x000f3;</surname><given-names>M.</given-names></name><name><surname>Caram&#x000e3;o</surname><given-names>E.B.</given-names></name><name><surname>Moreno</surname><given-names>P.R.H.</given-names></name><name><surname>Elisabetsky</surname><given-names>E.</given-names></name></person-group><article-title>Effects of inhaled linalool in anxiety, social interaction and aggressive behavior in mice</article-title><source>Phytomedicine</source><year>2010</year><volume>17</volume><fpage>679</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2009.10.002</pub-id><?supplied-pmid 19962290?><pub-id pub-id-type="pmid">19962290</pub-id></element-citation></ref><ref id="B63-molecules-23-01061"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Feng</surname><given-names>L.</given-names></name><name><surname>Yao</surname><given-names>L.</given-names></name></person-group><article-title>The anxiolytic effect of essential oil of Cananga odorata exposure on mice and determination of its major active constituents</article-title><source>Phytomedicine</source><year>2016</year><volume>23</volume><fpage>1727</fpage><lpage>1734</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2016.10.017</pub-id><?supplied-pmid 27912874?><pub-id pub-id-type="pmid">27912874</pub-id></element-citation></ref><ref id="B64-molecules-23-01061"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira-da-Silva</surname><given-names>F.W.</given-names></name><name><surname>da Silva-Alves</surname><given-names>K.S.</given-names></name><name><surname>Alves-Fernandes</surname><given-names>T.A.</given-names></name><name><surname>Coelho-de-Souza</surname><given-names>A.N.</given-names></name><name><surname>Leal-Cardoso</surname><given-names>J.H.</given-names></name></person-group><article-title>Effects of 1,8-cineole on Na(+) currents of dissociated superior cervical ganglia neurons</article-title><source>Neurosci. Lett.</source><year>2015</year><volume>595</volume><fpage>45</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2015.04.005</pub-id><?supplied-pmid 25849529?><pub-id pub-id-type="pmid">25849529</pub-id></element-citation></ref><ref id="B65-molecules-23-01061"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeraatpisheh</surname><given-names>Z.</given-names></name><name><surname>Vatanparast</surname><given-names>J.</given-names></name></person-group><article-title>Eucalyptol induces hyperexcitability and epileptiform activity in snail neurons by inhibiting potassium channels</article-title><source>Eur. J. Pharmacol.</source><year>2015</year><volume>764</volume><fpage>70</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2015.06.050</pub-id><?supplied-pmid 26134504?><pub-id pub-id-type="pmid">26134504</pub-id></element-citation></ref><ref id="B66-molecules-23-01061"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oyemitan</surname><given-names>I.A.</given-names></name><name><surname>Elusiyan</surname><given-names>C.A.</given-names></name><name><surname>Akanmu</surname><given-names>M.A.</given-names></name><name><surname>Olugbade</surname><given-names>T.A.</given-names></name></person-group><article-title>Hypnotic, anticonvulsant and anxiolytic effects of 1-nitro-2-phenylethane isolated from the essential oil of <italic>Dennettia tripetala</italic> in mice</article-title><source>Phytomedicine</source><year>2013</year><volume>20</volume><fpage>1315</fpage><lpage>1322</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2013.07.005</pub-id><?supplied-pmid 23920280?><pub-id pub-id-type="pmid">23920280</pub-id></element-citation></ref><ref id="B67-molecules-23-01061"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arruda-Barbosa</surname><given-names>L.</given-names></name><name><surname>Rodrigues</surname><given-names>K.M.</given-names></name><name><surname>Souza-Neto</surname><given-names>F.D.</given-names></name><name><surname>Duarte</surname><given-names>G.P.</given-names></name><name><surname>Borges</surname><given-names>R.S.</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>P.J.</given-names></name><name><surname>Lahlou</surname><given-names>S.</given-names></name></person-group><article-title>Vasorelaxant effects of 1-nitro-2-phenylethene in rat isolated aortic rings</article-title><source>Vasc. Pharmacol.</source><year>2014</year><volume>63</volume><fpage>55</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.vph.2014.08.002</pub-id><?supplied-pmid 25131395?><pub-id pub-id-type="pmid">25131395</pub-id></element-citation></ref><ref id="B68-molecules-23-01061"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Interaminense Lde</surname><given-names>F.</given-names></name><name><surname>dos Ramos-Alves</surname><given-names>F.E.</given-names></name><name><surname>de Siqueira</surname><given-names>R.J.</given-names></name><name><surname>Xavier</surname><given-names>F.E.</given-names></name><name><surname>Duarte</surname><given-names>G.P.</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>P.J.</given-names></name><name><surname>Maia</surname><given-names>J.G.</given-names></name><name><surname>Sousa</surname><given-names>P.J.</given-names></name><name><surname>Lahlou</surname><given-names>S.</given-names></name></person-group><article-title>Vasorelaxant effects of 1-nitro-2-phenylethane, the main constituent of the essential oil of <italic>Aniba canelilla</italic>, in superior mesenteric arteries from spontaneously hypertensive rats</article-title><source>Eur. J. Pharm. Sci.</source><year>2013</year><volume>48</volume><fpage>709</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1016/j.ejps.2012.12.033</pub-id><?supplied-pmid 23313621?><pub-id pub-id-type="pmid">23313621</pub-id></element-citation></ref><ref id="B69-molecules-23-01061"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>J.</given-names></name><name><surname>Shen</surname><given-names>Y.Y.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>Y.H.</given-names></name><name><surname>Luo</surname><given-names>C.X.</given-names></name><name><surname>Zhu</surname><given-names>D.Y.</given-names></name></person-group><article-title>(+)-Borneol alleviates mechanical hyperalgesia in models of chronic inflammatory and neuropathic pain in mice</article-title><source>Eur. J. Pharmacol.</source><year>2015</year><volume>757</volume><fpage>53</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2015.03.056</pub-id><?supplied-pmid 25835611?><pub-id pub-id-type="pmid">25835611</pub-id></element-citation></ref><ref id="B70-molecules-23-01061"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garlet</surname><given-names>Q.I.</given-names></name><name><surname>Pires</surname><given-names>L.C.</given-names></name><name><surname>Silva</surname><given-names>D.T.</given-names></name><name><surname>Spall</surname><given-names>S.</given-names></name><name><surname>Gressler</surname><given-names>L.T.</given-names></name><name><surname>B&#x000fc;rger</surname><given-names>M.E.</given-names></name><name><surname>Baldisserotto</surname><given-names>B.</given-names></name><name><surname>Heinzmann</surname><given-names>B.M.</given-names></name></person-group><article-title>Effect of (+)-dehydrofukinone on GABAA receptors and stress response in fish model</article-title><source>Braz. J. Med. Biol. Res.</source><year>2016</year><volume>49</volume><fpage>e4872</fpage><pub-id pub-id-type="doi">10.1590/1414-431X20154872</pub-id><?supplied-pmid 26628396?><pub-id pub-id-type="pmid">26628396</pub-id></element-citation></ref><ref id="B71-molecules-23-01061"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>W.</given-names></name><name><surname>Yoshioka</surname><given-names>M.</given-names></name><name><surname>Yokogoshi</surname><given-names>H.</given-names></name></person-group><article-title>Sub-chronic effects of s-limonene on brain neurotransmitter levels and behavior of rats</article-title><source>J. Nutr. Sci. Vitaminol.</source><year>2009</year><volume>55</volume><fpage>367</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.3177/jnsv.55.367</pub-id><?supplied-pmid 19763039?><pub-id pub-id-type="pmid">19763039</pub-id></element-citation></ref><ref id="B72-molecules-23-01061"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lima</surname><given-names>N.G.</given-names></name><name><surname>De Sousa</surname><given-names>D.P.</given-names></name><name><surname>Pimenta</surname><given-names>F.C.</given-names></name><name><surname>Alves</surname><given-names>M.F.</given-names></name><name><surname>De Souza</surname><given-names>F.S.</given-names></name><name><surname>Macedo</surname><given-names>R.O.</given-names></name><name><surname>Cardoso</surname><given-names>R.B.</given-names></name><name><surname>de Morais</surname><given-names>L.C.</given-names></name><name><surname>Melo Diniz Mde</surname><given-names>F.</given-names></name><name><surname>de Almeida</surname><given-names>R.N.</given-names></name></person-group><article-title>Anxiolytic-like activity and GC-MS analysis of (<italic>R</italic>)-(+)-limonene fragrance, a natural compound found in foods and plants</article-title><source>Pharmacol. Biochem. Behav.</source><year>2013</year><volume>103</volume><fpage>450</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1016/j.pbb.2012.09.005</pub-id><?supplied-pmid 22995322?><pub-id pub-id-type="pmid">22995322</pub-id></element-citation></ref><ref id="B73-molecules-23-01061"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garlet</surname><given-names>Q.I.</given-names></name><name><surname>Pires</surname><given-names>L.D.C.</given-names></name><name><surname>Milanesi</surname><given-names>L.H.</given-names></name><name><surname>Marafiga</surname><given-names>J.R.</given-names></name><name><surname>Baldisserotto</surname><given-names>B.</given-names></name><name><surname>Mello</surname><given-names>C.F.</given-names></name><name><surname>Heinzmann</surname><given-names>B.M.</given-names></name></person-group><article-title>(+)-Dehydrofukinone modulates membrane potential and delays seizure onset by GABAa receptor-mediated mechanism in mice</article-title><source>Toxicol. Appl. Pharmacol.</source><year>2017</year><volume>332</volume><fpage>52</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.taap.2017.07.010</pub-id><?supplied-pmid 28733205?><pub-id pub-id-type="pmid">28733205</pub-id></element-citation></ref><ref id="B74-molecules-23-01061"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alves Ade</surname><given-names>M.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>J.C.</given-names></name><name><surname>Cruz</surname><given-names>J.S.</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>D.A.</given-names></name></person-group><article-title>Evaluation of the sesquiterpene (&#x02212;)-alpha-bisabolol as a novel peripheral nervous blocker</article-title><source>Neurosci Lett.</source><year>2010</year><volume>472</volume><fpage>11</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2010.01.042</pub-id><?supplied-pmid 20105451?><pub-id pub-id-type="pmid">20105451</pub-id></element-citation></ref><ref id="B75-molecules-23-01061"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Woo</surname><given-names>J.</given-names></name><name><surname>Pae</surname><given-names>A.N.</given-names></name><name><surname>Um</surname><given-names>M.Y.</given-names></name><name><surname>Cho</surname><given-names>N.C.</given-names></name><name><surname>Park</surname><given-names>K.D.</given-names></name><name><surname>Yoon</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>C.J.</given-names></name><name><surname>Cho</surname><given-names>S.</given-names></name></person-group><article-title>&#x003b1;-Pinene, a major constituent of pine tree oils, enhances non-rapid eye movement sleep in mice through GABAA-benzodiazepine receptors</article-title><source>Mol. Pharmacol.</source><year>2016</year><volume>90</volume><fpage>530</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1124/mol.116.105080</pub-id><?supplied-pmid 27573669?><pub-id pub-id-type="pmid">27573669</pub-id></element-citation></ref><ref id="B76-molecules-23-01061"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasconcelos</surname><given-names>T.B.</given-names></name><name><surname>Ribeiro-Filho</surname><given-names>H.V.</given-names></name><name><surname>Lucetti</surname><given-names>L.T.</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>P.J.</given-names></name></person-group><article-title>&#x003b2;-Citronellol, an alcoholic monoterpene with inhibitory properties on the contractility of rat trachea</article-title><source>Braz. J. Med. Biol. Res.</source><year>2016</year><volume>49</volume><fpage>e4800</fpage><pub-id pub-id-type="doi">10.1590/1414-431X20154800</pub-id><?supplied-pmid 26648088?><pub-id pub-id-type="pmid">26648088</pub-id></element-citation></ref><ref id="B77-molecules-23-01061"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nogoceke</surname><given-names>F.P.</given-names></name><name><surname>Barcaro</surname><given-names>I.M.</given-names></name><name><surname>de Sousa</surname><given-names>D.P.</given-names></name><name><surname>Andreatini</surname><given-names>R.</given-names></name></person-group><article-title>Antimanic-like effects of (<italic>R</italic>)-(&#x02212;)-carvone and (<italic>S</italic>)-(+)-carvone in mice</article-title><source>Neurosci. Lett.</source><year>2016</year><volume>619</volume><fpage>43</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2016.03.013</pub-id><?supplied-pmid 26970377?><pub-id pub-id-type="pmid">26970377</pub-id></element-citation></ref><ref id="B78-molecules-23-01061"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trailovi&#x00107;</surname><given-names>S.M.</given-names></name><name><surname>Marjanovi&#x00107;</surname><given-names>D.S.</given-names></name><name><surname>Nedeljkovi&#x00107; Trailovi&#x00107;</surname><given-names>J.</given-names></name><name><surname>Robertson</surname><given-names>A.P.</given-names></name><name><surname>Martin</surname><given-names>R.J.</given-names></name></person-group><article-title>Interaction of carvacrol with the Ascaris suum nicotinic acetylcholine receptors and gamma-aminobutyric acid receptors, potential mechanism of antinematodal action</article-title><source>Parasitol. Res.</source><year>2015</year><volume>114</volume><fpage>3059</fpage><lpage>3068</lpage><pub-id pub-id-type="doi">10.1007/s00436-015-4508-x</pub-id><?supplied-pmid 25944741?><pub-id pub-id-type="pmid">25944741</pub-id></element-citation></ref><ref id="B79-molecules-23-01061"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joca</surname><given-names>H.C.</given-names></name><name><surname>Cruz-Mendes</surname><given-names>Y.</given-names></name><name><surname>Oliveira-Abreu</surname><given-names>K.</given-names></name><name><surname>Maia-Joca</surname><given-names>R.P.</given-names></name><name><surname>Barbosa</surname><given-names>R.</given-names></name><name><surname>Lemos</surname><given-names>T.L.</given-names></name><name><surname>Lacerda Beir&#x000e3;o</surname><given-names>P.S.</given-names></name><name><surname>Leal-Cardoso</surname><given-names>J.H.</given-names></name></person-group><article-title>Carvacrol decreases neuronal excitability by inhibition of voltage-gated sodium channels</article-title><source>J. Nat. Prod.</source><year>2012</year><volume>75</volume><fpage>1511</fpage><lpage>1517</lpage><pub-id pub-id-type="doi">10.1021/np300050g</pub-id><?supplied-pmid 22967040?><pub-id pub-id-type="pmid">22967040</pub-id></element-citation></ref><ref id="B80-molecules-23-01061"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joca</surname><given-names>H.C.</given-names></name><name><surname>Vieira</surname><given-names>D.C.</given-names></name><name><surname>Vasconcelos</surname><given-names>A.P.</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>D.A.</given-names></name><name><surname>Cruz</surname><given-names>J.S.</given-names></name></person-group><article-title>Carvacrol modulates voltage-gated sodium channels kinetics in dorsal root ganglia</article-title><source>Eur. J. Pharmacol.</source><year>2015</year><volume>756</volume><fpage>22</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2015.03.007</pub-id><?supplied-pmid 25794844?><pub-id pub-id-type="pmid">25794844</pub-id></element-citation></ref><ref id="B81-molecules-23-01061"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melo</surname><given-names>F.H.</given-names></name><name><surname>Ven&#x000e2;ncio</surname><given-names>E.T.</given-names></name><name><surname>de Sousa</surname><given-names>D.P.</given-names></name><name><surname>de Fran&#x000e7;a Fonteles</surname><given-names>M.M.</given-names></name><name><surname>de Vasconcelos</surname><given-names>S.M.</given-names></name><name><surname>Viana</surname><given-names>G.S.</given-names></name><name><surname>de Sousa</surname><given-names>F.C.</given-names></name></person-group><article-title>Anxiolytic-like effect of Carvacrol (5-isopropyl-2-methylphenol) in mice: Involvement with GABAergic transmission</article-title><source>Fundam. Clin. Pharmacol.</source><year>2010</year><volume>24</volume><fpage>437</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1111/j.1472-8206.2009.00788.x</pub-id><?supplied-pmid 19909350?><pub-id pub-id-type="pmid">19909350</pub-id></element-citation></ref><ref id="B82-molecules-23-01061"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva-Alves</surname><given-names>K.S.</given-names></name><name><surname>Ferreira-da-Silva</surname><given-names>F.W.</given-names></name><name><surname>Peixoto-Neves</surname><given-names>D.</given-names></name><name><surname>Viana-Cardoso</surname><given-names>K.V.</given-names></name><name><surname>Moreira-J&#x000fa;nior</surname><given-names>L.</given-names></name><name><surname>Oquendo</surname><given-names>M.B.</given-names></name><name><surname>Oliveira-Abreu</surname><given-names>K.</given-names></name><name><surname>Albuquerque</surname><given-names>A.A.</given-names></name><name><surname>Coelho-de-Souza</surname><given-names>A.N.</given-names></name><name><surname>Leal-Cardoso</surname><given-names>J.H.</given-names></name></person-group><article-title>Estragole blocks neuronal excitability by direct inhibition of Na+ channels</article-title><source>Braz. J. Med. Biol. Res.</source><year>2013</year><volume>46</volume><fpage>1056</fpage><lpage>1063</lpage><pub-id pub-id-type="doi">10.1590/1414-431X20133191</pub-id><?supplied-pmid 24345915?><pub-id pub-id-type="pmid">24345915</pub-id></element-citation></ref><ref id="B83-molecules-23-01061"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vatanparast</surname><given-names>J.</given-names></name><name><surname>Khalili</surname><given-names>S.</given-names></name><name><surname>Naseh</surname><given-names>M.</given-names></name></person-group><article-title>Dual effects of eugenol on the neuronal excitability: An in vitro study</article-title><source>Neurotoxicology</source><year>2017</year><volume>58</volume><fpage>84</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.neuro.2016.11.011</pub-id><?supplied-pmid 27894698?><pub-id pub-id-type="pmid">27894698</pub-id></element-citation></ref><ref id="B84-molecules-23-01061"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>M.I.</given-names></name><name><surname>Silva</surname><given-names>M.A.</given-names></name><name><surname>de Aquino Neto</surname><given-names>M.R.</given-names></name><name><surname>Moura</surname><given-names>B.A.</given-names></name><name><surname>de Sousa</surname><given-names>H.L.</given-names></name><name><surname>de Lavor</surname><given-names>E.P.</given-names></name><name><surname>de Vasconcelos</surname><given-names>P.F.</given-names></name><name><surname>Mac&#x000ea;do</surname><given-names>D.S.</given-names></name><name><surname>de Sousa</surname><given-names>D.P.</given-names></name><name><surname>Vasconcelos</surname><given-names>S.M.</given-names></name><etal/></person-group><article-title>Effects of isopulegol on pentylenetetrazol-induced convulsions in mice: possible involvement of GABAergic system and antioxidant activity</article-title><source>Fitoterapia</source><year>2009</year><volume>80</volume><fpage>506</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2009.06.011</pub-id><?supplied-pmid 19559770?><pub-id pub-id-type="pmid">19559770</pub-id></element-citation></ref><ref id="B85-molecules-23-01061"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leal-Cardoso</surname><given-names>J.H.</given-names></name><name><surname>da Silva-Alves</surname><given-names>K.S.</given-names></name><name><surname>Ferreira-da-Silva</surname><given-names>F.W.</given-names></name><name><surname>dos Santos-Nascimento</surname><given-names>T.</given-names></name><name><surname>Joca</surname><given-names>H.C.</given-names></name><name><surname>de Macedo</surname><given-names>F.H.</given-names></name><name><surname>de Albuquerque-Neto</surname><given-names>P.M.</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>P.J.</given-names></name><name><surname>Lahlou</surname><given-names>S.</given-names></name><name><surname>Cruz</surname><given-names>J.S.</given-names></name><etal/></person-group><article-title>Linalool blocks excitability in peripheral nerves and voltage-dependent Na+ current in dissociated dorsal root ganglia neurons</article-title><source>Eur. J. Pharmacol.</source><year>2010</year><volume>645</volume><fpage>86</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2010.07.014</pub-id><?supplied-pmid 20655301?><pub-id pub-id-type="pmid">20655301</pub-id></element-citation></ref><ref id="B86-molecules-23-01061"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawasaki</surname><given-names>H.</given-names></name><name><surname>Mizuta</surname><given-names>K.</given-names></name><name><surname>Fujita</surname><given-names>T.</given-names></name><name><surname>Kumamoto</surname><given-names>E.</given-names></name></person-group><article-title>Inhibition by menthol and its related chemicals of compound action potentials in frog sciatic nerves</article-title><source>Life Sci.</source><year>2013</year><volume>92</volume><fpage>359</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2013.01.012</pub-id><?supplied-pmid 23352972?><pub-id pub-id-type="pmid">23352972</pub-id></element-citation></ref><ref id="B87-molecules-23-01061"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Peng</surname><given-names>Z.</given-names></name><name><surname>Xie</surname><given-names>Y.</given-names></name><name><surname>Deng</surname><given-names>S.</given-names></name><name><surname>Nie</surname><given-names>Y.Z.</given-names></name><name><surname>Xu</surname><given-names>T.L.</given-names></name><name><surname>Ge</surname><given-names>W.H.</given-names></name><name><surname>Li</surname><given-names>W.G.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name></person-group><article-title>Electrophysiological characterization of methyleugenol: A novel agonist of GABA(A) receptors</article-title><source>ACS Chem. Neurosci.</source><year>2014</year><volume>5</volume><fpage>803</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1021/cn500022e</pub-id><?supplied-pmid 24980777?><pub-id pub-id-type="pmid">24980777</pub-id></element-citation></ref><ref id="B88-molecules-23-01061"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yano</surname><given-names>S.</given-names></name><name><surname>Suzuki</surname><given-names>Y.</given-names></name><name><surname>Yuzurihara</surname><given-names>M.</given-names></name><name><surname>Kase</surname><given-names>Y.</given-names></name><name><surname>Takeda</surname><given-names>S.</given-names></name><name><surname>Watanabe</surname><given-names>S.</given-names></name><name><surname>Aburada</surname><given-names>M.</given-names></name><name><surname>Miyamoto</surname><given-names>K.</given-names></name></person-group><article-title>Antinociceptive effect of methyleugenol on formalin-induced hyperalgesia in mice</article-title><source>Eur. J. Pharmacol.</source><year>2006</year><volume>553</volume><fpage>99</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2006.09.020</pub-id><?supplied-pmid 17049512?><pub-id pub-id-type="pmid">17049512</pub-id></element-citation></ref><ref id="B89-molecules-23-01061"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fons&#x000ea;ca</surname><given-names>D.V.</given-names></name><name><surname>Salgado</surname><given-names>P.R.</given-names></name><name><surname>de Carvalho</surname><given-names>F.L.</given-names></name><name><surname>Salvadori</surname><given-names>M.G.</given-names></name><name><surname>Penha</surname><given-names>A.R.</given-names></name><name><surname>Leite</surname><given-names>F.C.</given-names></name><name><surname>Borges</surname><given-names>C.J.</given-names></name><name><surname>Piuvezam</surname><given-names>M.R.</given-names></name><name><surname>Pordeus</surname><given-names>L.C.</given-names></name><name><surname>Sousa</surname><given-names>D.P.</given-names></name><etal/></person-group><article-title>Nerolidol exhibits antinociceptive and anti-inflammatory activity: Involvement of the GABAergic system and proinflammatory cytokines</article-title><source>Fundam. Clin. Pharmacol.</source><year>2016</year><volume>30</volume><fpage>14</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1111/fcp.12166</pub-id><?supplied-pmid 26791997?><pub-id pub-id-type="pmid">26791997</pub-id></element-citation></ref><ref id="B90-molecules-23-01061"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>N&#x000f3;brega</surname><given-names>F.F.</given-names></name><name><surname>Salvadori</surname><given-names>M.G.</given-names></name><name><surname>Masson</surname><given-names>C.J.</given-names></name><name><surname>Mello</surname><given-names>C.F.</given-names></name><name><surname>Nascimento</surname><given-names>T.S.</given-names></name><name><surname>Leal-Cardoso</surname><given-names>J.H.</given-names></name><name><surname>de Sousa</surname><given-names>D.P.</given-names></name><name><surname>Almeida</surname><given-names>R.N.</given-names></name></person-group><article-title>Monoterpenoid terpinen-4-ol exhibits anticonvulsant activity in behavioural and electrophysiological studies</article-title><source>Oxid. Med. Cell Longev.</source><year>2014</year><volume>2014</volume><pub-id pub-id-type="doi">10.1155/2014/703848</pub-id><?supplied-pmid 25180069?><pub-id pub-id-type="pmid">25180069</pub-id></element-citation></ref><ref id="B91-molecules-23-01061"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariani</surname><given-names>M.E.</given-names></name><name><surname>S&#x000e1;nchez-Borzone</surname><given-names>M.E.</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>D.A.</given-names></name></person-group><article-title>Effects of bioactive monoterpenic ketones on membrane organization. A langmuir film study</article-title><source>Chem. Phys. Lipids</source><year>2016</year><volume>198</volume><fpage>39</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.chemphyslip.2016.05.002</pub-id><?supplied-pmid 27174212?><pub-id pub-id-type="pmid">27174212</pub-id></element-citation></ref><ref id="B92-molecules-23-01061"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z.H.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Fujita</surname><given-names>T.</given-names></name><name><surname>Jiang</surname><given-names>C.Y.</given-names></name><name><surname>Kumamoto</surname><given-names>E.</given-names></name></person-group><article-title>Action of thymol on spontaneous excitatory transmission in adult rat spinal substantia gelatinosa neurons</article-title><source>Neurosci. Lett.</source><year>2015</year><volume>606</volume><fpage>94</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2015.08.042</pub-id><?supplied-pmid 26314510?><pub-id pub-id-type="pmid">26314510</pub-id></element-citation></ref><ref id="B93-molecules-23-01061"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Priestley</surname><given-names>C.M.</given-names></name><name><surname>Williamson</surname><given-names>E.M.</given-names></name><name><surname>Wafford</surname><given-names>K.A.</given-names></name><name><surname>Sattelle</surname><given-names>D.B.</given-names></name></person-group><article-title>Thymol, a constituent of thyme essential oil, is a positive allosteric modulator of human GABA(A) receptors and a homo-oligomeric GABA receptor from <italic>Drosophila melanogaster</italic></article-title><source>Br. J. Pharmacol.</source><year>2003</year><volume>140</volume><fpage>1363</fpage><lpage>1372</lpage><pub-id pub-id-type="doi">10.1038/sj.bjp.0705542</pub-id><?supplied-pmid 14623762?><pub-id pub-id-type="pmid">14623762</pub-id></element-citation></ref><ref id="B94-molecules-23-01061"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseinzadeh</surname><given-names>H.</given-names></name><name><surname>Parvardeh</surname><given-names>S.</given-names></name></person-group><article-title>Anticonvulsant effects of thymoquinone, the major constituent of <italic>Nigella sativa</italic> seeds, in mice</article-title><source>Phytomedicine</source><year>2004</year><volume>11</volume><fpage>56</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1078/0944-7113-00376</pub-id><?supplied-pmid 14971722?><pub-id pub-id-type="pmid">14971722</pub-id></element-citation></ref><ref id="B95-molecules-23-01061"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guimar&#x000e3;es</surname><given-names>A.G.</given-names></name><name><surname>Quintans</surname><given-names>J.S.</given-names></name><name><surname>Quintans</surname><given-names>L.J.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Monoterpenes with analgesic activity-a systematic review</article-title><source>Phytother. Res.</source><year>2013</year><volume>27</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1002/ptr.4686</pub-id><?supplied-pmid 23296806?><pub-id pub-id-type="pmid">23296806</pub-id></element-citation></ref><ref id="B96-molecules-23-01061"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lima-Accioly</surname><given-names>P.M.</given-names></name><name><surname>Lavor-Porto</surname><given-names>P.R.</given-names></name><name><surname>Cavalcante</surname><given-names>F.S.</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>P.J.</given-names></name><name><surname>Lahlou</surname><given-names>S.</given-names></name><name><surname>Morais</surname><given-names>S.M.</given-names></name><name><surname>Leal-Cardoso</surname><given-names>J.H.</given-names></name></person-group><article-title>Essential oil of croton nepetaefolius and its main constituent, 1,8-cineole, block excitability of rat sciatic nerve in vitro</article-title><source>Clin. Exp. Pharmacol. Physiol.</source><year>2006</year><volume>33</volume><fpage>1158</fpage><lpage>1163</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1681.2006.04494.x</pub-id><?supplied-pmid 17184495?><pub-id pub-id-type="pmid">17184495</pub-id></element-citation></ref><ref id="B97-molecules-23-01061"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira-da-Silva</surname><given-names>F.W.</given-names></name><name><surname>Barbosa</surname><given-names>R.</given-names></name><name><surname>Moreira-J&#x000fa;nior</surname><given-names>L.</given-names></name><name><surname>dos Santos-Nascimento</surname><given-names>T.</given-names></name><name><surname>de Oliveira-Martins</surname><given-names>M.D.</given-names></name><name><surname>Coelho-de-Souza</surname><given-names>A.N.</given-names></name><name><surname>Cavalcante</surname><given-names>F.S.</given-names></name><name><surname>Ceccatto</surname><given-names>V.M.</given-names></name><name><surname>de Lemos</surname><given-names>T.L.</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>P.J.</given-names></name><etal/></person-group><article-title>Effects of 1,8-cineole on electrophysiological parameters of neurons of the rat superior cervical ganglion</article-title><source>Clin. Exp. Pharmacol. Physiol.</source><year>2009</year><volume>36</volume><fpage>1068</fpage><lpage>1073</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1681.2009.05188.x</pub-id><?supplied-pmid 19413602?><pub-id pub-id-type="pmid">19413602</pub-id></element-citation></ref><ref id="B98-molecules-23-01061"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesage-Meessen</surname><given-names>L.</given-names></name><name><surname>Bou</surname><given-names>M.</given-names></name><name><surname>Sigoillot</surname><given-names>J.C.</given-names></name><name><surname>Faulds</surname><given-names>C.B.</given-names></name><name><surname>Lomascolo</surname><given-names>A.</given-names></name></person-group><article-title>Essential oils and distilled straws of lavender and lavandin: A review of current use and potential application in white biotechnology</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2015</year><volume>99</volume><fpage>3375</fpage><lpage>3385</lpage><pub-id pub-id-type="doi">10.1007/s00253-015-6511-7</pub-id><?supplied-pmid 25761625?><pub-id pub-id-type="pmid">25761625</pub-id></element-citation></ref><ref id="B99-molecules-23-01061"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linck</surname><given-names>V.M.</given-names></name><name><surname>da Silva</surname><given-names>A.L.</given-names></name><name><surname>Figueir&#x000f3;</surname><given-names>M.</given-names></name><name><surname>Piato</surname><given-names>A.L.</given-names></name><name><surname>Herrmann</surname><given-names>A.P.</given-names></name><name><surname>Dupont Birck</surname><given-names>F.</given-names></name><name><surname>Caram&#x000e3;o</surname><given-names>E.B.</given-names></name><name><surname>Nunes</surname><given-names>D.S.</given-names></name><name><surname>Moreno</surname><given-names>P.R.</given-names></name><name><surname>Elisabetsky</surname><given-names>E.</given-names></name></person-group><article-title>Inhaled linalool induced sedation in mice</article-title><source>Phytomedicine</source><year>2009</year><volume>16</volume><fpage>303</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2008.08.001</pub-id><?supplied-pmid 18824339?><pub-id pub-id-type="pmid">18824339</pub-id></element-citation></ref><ref id="B100-molecules-23-01061"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsang</surname><given-names>H.W.</given-names></name><name><surname>Ho</surname><given-names>T.Y.</given-names></name></person-group><article-title>A systematic review on the anxiolytic effects of aromatherapy on rodents under experimentally induced anxiety models</article-title><source>Rev. Neurosci.</source><year>2010</year><volume>21</volume><fpage>141</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1515/REVNEURO.2010.21.2.141</pub-id><?supplied-pmid 20614803?><pub-id pub-id-type="pmid">20614803</pub-id></element-citation></ref><ref id="B101-molecules-23-01061"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umezu</surname><given-names>T.</given-names></name><name><surname>Nagano</surname><given-names>K.</given-names></name><name><surname>Ito</surname><given-names>H.</given-names></name><name><surname>Kosakai</surname><given-names>K.</given-names></name><name><surname>Sakaniwa</surname><given-names>M.</given-names></name><name><surname>Morita</surname><given-names>M.</given-names></name></person-group><article-title>Anticonflict effects of lavender oil and identification of its active constituents</article-title><source>Pharmacol. Biochem. Behav.</source><year>2006</year><volume>85</volume><fpage>713</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.1016/j.pbb.2006.10.026</pub-id><?supplied-pmid 17173962?><pub-id pub-id-type="pmid">17173962</pub-id></element-citation></ref><ref id="B102-molecules-23-01061"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Sousa</surname><given-names>D.P.</given-names></name><name><surname>de Farias N&#x000f3;brega</surname><given-names>F.F.</given-names></name><name><surname>de Almeida</surname><given-names>R.N.</given-names></name></person-group><article-title>Influence of the chirality of (<italic>R</italic>)-(&#x02212;)- and (<italic>S</italic>)-(+)-carvone in the central nervous system: A comparative study</article-title><source>Chirality</source><year>2007</year><volume>19</volume><fpage>264</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1002/chir.20379</pub-id><?supplied-pmid 17299731?><pub-id pub-id-type="pmid">17299731</pub-id></element-citation></ref><ref id="B103-molecules-23-01061"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gon&#x000e7;alves</surname><given-names>J.C.</given-names></name><name><surname>Oliveira Fde</surname><given-names>S.</given-names></name><name><surname>Benedito</surname><given-names>R.B.</given-names></name><name><surname>de Sousa</surname><given-names>D.P.</given-names></name><name><surname>de Almeida</surname><given-names>R.N.</given-names></name><name><surname>de Ara&#x000fa;jo</surname><given-names>D.A.</given-names></name></person-group><article-title>Antinociceptive activity of (&#x02212;)-carvone: Evidence of association with decreased peripheral nerve excitability</article-title><source>Biol. Pharm. Bull.</source><year>2008</year><volume>31</volume><fpage>1017</fpage><lpage>1020</lpage><pub-id pub-id-type="doi">10.1248/bpb.31.1017</pub-id><?supplied-pmid 18451538?><pub-id pub-id-type="pmid">18451538</pub-id></element-citation></ref><ref id="B104-molecules-23-01061"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gon&#x000e7;alves</surname><given-names>J.C.</given-names></name><name><surname>Alves Ade</surname><given-names>M.</given-names></name><name><surname>de Ara&#x000fa;jo</surname><given-names>A.E.</given-names></name><name><surname>Cruz</surname><given-names>J.S.</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>D.A.</given-names></name></person-group><article-title>Distinct effects of carvone analogues on the isolated nerve of rats</article-title><source>Eur. J. Pharmacol.</source><year>2010</year><volume>645</volume><fpage>108</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2010.07.027</pub-id><?supplied-pmid 20670618?><pub-id pub-id-type="pmid">20670618</pub-id></element-citation></ref><ref id="B105-molecules-23-01061"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>Q.</given-names></name><name><surname>Jiang</surname><given-names>C.Y.</given-names></name><name><surname>Fujita</surname><given-names>T.</given-names></name><name><surname>Kumamoto</surname><given-names>E.</given-names></name></person-group><article-title>Spontaneous L-glutamate release enhancement in rat substantia gelatinosa neurons by (&#x02212;)-carvone and (+)-carvone which activate different types of TRP channel</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2015</year><volume>459</volume><fpage>498</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2015.02.135</pub-id><?supplied-pmid 25747716?><pub-id pub-id-type="pmid">25747716</pub-id></element-citation></ref><ref id="B106-molecules-23-01061"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angeles-L&#x000f3;pez</surname><given-names>G.</given-names></name><name><surname>P&#x000e9;rez-V&#x000e1;squez</surname><given-names>A.</given-names></name><name><surname>Hern&#x000e1;ndez-Luis</surname><given-names>F.</given-names></name><name><surname>D&#x000e9;ciga-Campos</surname><given-names>M.</given-names></name><name><surname>Bye</surname><given-names>R.</given-names></name><name><surname>Linares</surname><given-names>E.</given-names></name><name><surname>Mata</surname><given-names>R.</given-names></name></person-group><article-title>Antinociceptive effect of extracts and compounds from Hofmeisteria schaffneri</article-title><source>J. Ethnopharmacol.</source><year>2010</year><volume>131</volume><fpage>425</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2010.07.009</pub-id><?supplied-pmid 20633627?><pub-id pub-id-type="pmid">20633627</pub-id></element-citation></ref><ref id="B107-molecules-23-01061"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Delling</surname><given-names>M.</given-names></name><name><surname>Jun</surname><given-names>J.C.</given-names></name><name><surname>Clapham</surname><given-names>D.E.</given-names></name></person-group><article-title>Oregano, thyme and clove-derived flavors and skin sensitizers activate specific TRP channels</article-title><source>Nat. Neurosci.</source><year>2006</year><volume>9</volume><fpage>628</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1038/nn1692</pub-id><?supplied-pmid 16617338?><pub-id pub-id-type="pmid">16617338</pub-id></element-citation></ref><ref id="B108-molecules-23-01061"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spadaro</surname><given-names>F.</given-names></name><name><surname>Costa</surname><given-names>R.</given-names></name><name><surname>Circosta</surname><given-names>C.</given-names></name><name><surname>Occhiuto</surname><given-names>F.</given-names></name></person-group><article-title>Volatile composition and biological activity of key lime <italic>Citrus aurantifolia</italic> essential oil</article-title><source>Nat. Prod. Commun.</source><year>2012</year><volume>7</volume><fpage>1523</fpage><lpage>1526</lpage><?supplied-pmid 23285822?><pub-id pub-id-type="pmid">23285822</pub-id></element-citation></ref><ref id="B109-molecules-23-01061"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pultrini Ade</surname><given-names>M.</given-names></name><name><surname>Galindo</surname><given-names>L.A.</given-names></name><name><surname>Costa</surname><given-names>M.</given-names></name></person-group><article-title>Effects of the essential oil from <italic>Citrus aurantium</italic> L. in experimental anxiety models in mice</article-title><source>Life Sci.</source><year>2006</year><volume>78</volume><fpage>1720</fpage><lpage>1725</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2005.08.004</pub-id><?supplied-pmid 16253279?><pub-id pub-id-type="pmid">16253279</pub-id></element-citation></ref><ref id="B110-molecules-23-01061"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilhotra</surname><given-names>N.</given-names></name><name><surname>Dhingra</surname><given-names>D.</given-names></name></person-group><article-title>Thymoquinone produced antianxiety-like effects in mice through modulation of GABA and NO levels</article-title><source>Pharmacol. Rep.</source><year>2011</year><volume>63</volume><fpage>660</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1016/S1734-1140(11)70577-1</pub-id><pub-id pub-id-type="pmid">21857076</pub-id></element-citation></ref><ref id="B111-molecules-23-01061"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000fc;ntar</surname><given-names>I.</given-names></name><name><surname>Tumen</surname><given-names>I.</given-names></name><name><surname>Ust&#x000fc;n</surname><given-names>O.</given-names></name><name><surname>Keles</surname><given-names>H.</given-names></name><name><surname>Akkol</surname><given-names>E.K.</given-names></name></person-group><article-title>Appraisal on the wound healing and anti-inflammatory activities of the essential oils obtained from the cones and needles of Pinus species by in vivo and in vitro experimental models</article-title><source>J. Ethnopharmacol.</source><year>2012</year><volume>139</volume><fpage>533</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2011.11.045</pub-id><?supplied-pmid 22155393?><pub-id pub-id-type="pmid">22155393</pub-id></element-citation></ref><ref id="B112-molecules-23-01061"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name></person-group><article-title>Chemical composition and antioxidant activity of essential oil of six pinus taxa native to China</article-title><source>Molecules</source><year>2015</year><volume>20</volume><fpage>9380</fpage><lpage>9392</lpage><pub-id pub-id-type="doi">10.3390/molecules20059380</pub-id><?supplied-pmid 26007189?><pub-id pub-id-type="pmid">26007189</pub-id></element-citation></ref><ref id="B113-molecules-23-01061"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Judzentiene</surname><given-names>A.</given-names></name><name><surname>Kupcinskiene</surname><given-names>E.</given-names></name></person-group><article-title>Chemical composition on essential oils from needles of <italic>Pinus sylvestris</italic> L. grown in northern Lithuania</article-title><source>J. Essent. Oil Res.</source><year>2008</year><volume>20</volume><fpage>26</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1080/10412905.2008.9699413</pub-id></element-citation></ref><ref id="B114-molecules-23-01061"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>A.</given-names></name><name><surname>Sahin-Nadeem</surname><given-names>H.</given-names></name><name><surname>Lummis</surname><given-names>S.C.</given-names></name><name><surname>Weigel</surname><given-names>I.</given-names></name><name><surname>Pischetsrieder</surname><given-names>M.</given-names></name><name><surname>Buettner</surname><given-names>A.</given-names></name><name><surname>Villmann</surname><given-names>C.</given-names></name></person-group><article-title>GABA(A) receptor modulation by terpenoids from <italic>Sideritis extracts</italic></article-title><source>Mol. Nutr. Food Res.</source><year>2014</year><volume>58</volume><fpage>851</fpage><lpage>862</lpage><pub-id pub-id-type="doi">10.1002/mnfr.201300420</pub-id><?supplied-pmid 24273211?><pub-id pub-id-type="pmid">24273211</pub-id></element-citation></ref><ref id="B115-molecules-23-01061"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oyemitan</surname><given-names>I.A.</given-names></name><name><surname>Iwalewa</surname><given-names>E.O.</given-names></name><name><surname>Akanmu</surname><given-names>M.A.</given-names></name><name><surname>Olugbade</surname><given-names>T.A.</given-names></name></person-group><article-title>Antinociceptive and antiinflammatory effects of essential oil of <italic>Dennettia tripetala</italic> G. Baker (Annonaceae) in rodents</article-title><source>Afr. J. Tradit. Complement. Altern. Med.</source><year>2008</year><volume>5</volume><fpage>355</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.4314/ajtcam.v5i4.31290</pub-id><?supplied-pmid 20161957?><pub-id pub-id-type="pmid">20161957</pub-id></element-citation></ref><ref id="B116-molecules-23-01061"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x000f6;ld</surname><given-names>K.M.</given-names></name><name><surname>Sirisoma</surname><given-names>N.S.</given-names></name><name><surname>Ikeda</surname><given-names>T.</given-names></name><name><surname>Narahashi</surname><given-names>T.</given-names></name><name><surname>Casida</surname><given-names>J.E.</given-names></name></person-group><article-title>Alpha-thujone (the active component of absinthe): Gamma-aminobutyric acid type a receptor modulation and metabolic detoxification</article-title><source>Proc. Natl. Acad. Sci USA</source><year>2000</year><volume>97</volume><fpage>3826</fpage><lpage>3831</lpage><pub-id pub-id-type="doi">10.1073/pnas.070042397</pub-id><?supplied-pmid 10725394?><pub-id pub-id-type="pmid">10725394</pub-id></element-citation></ref><ref id="B117-molecules-23-01061"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiner</surname><given-names>G.N.</given-names></name><name><surname>Delgado-Mar&#x000ed;n</surname><given-names>L.</given-names></name><name><surname>Olgu&#x000ed;n</surname><given-names>N.</given-names></name><name><surname>S&#x000e1;nchez-Redondo</surname><given-names>S.</given-names></name><name><surname>S&#x000e1;nchez-Borzone</surname><given-names>M.</given-names></name><name><surname>Rodr&#x000ed;guez-Farr&#x000e9;</surname><given-names>E.</given-names></name><name><surname>Su&#x000f1;ol</surname><given-names>C.</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>D.A.</given-names></name></person-group><article-title>GABAergic pharmacological activity of propofol related compounds as possible enhancers of general anesthetics and interaction with membranes</article-title><source>Cell Biochem. Biophys.</source><year>2013</year><volume>67</volume><fpage>515</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1007/s12013-013-9537-4</pub-id><?supplied-pmid 23456454?><pub-id pub-id-type="pmid">23456454</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="molecules-23-01061-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>The chemical structures of terpenes with analgesic properties targeting the Na<sup>+</sup> and transient receptor potential (TRP) channels.</p></caption><graphic xlink:href="molecules-23-01061-g001"/></fig><fig id="molecules-23-01061-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>The chemical structures of terpenes with analgesic and anticonvulsant properties targeting GABA<sub>A</sub> receptors.</p></caption><graphic xlink:href="molecules-23-01061-g002"/></fig><fig id="molecules-23-01061-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>The chemical structures of phenylpropanoid derivatives with analgesic properties.</p></caption><graphic xlink:href="molecules-23-01061-g003"/></fig><fig id="molecules-23-01061-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>The chemical structures of terpenes with anxiolytic targeting GABA<sub>A</sub> receptors.</p></caption><graphic xlink:href="molecules-23-01061-g004"/></fig><fig id="molecules-23-01061-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>The non-terpene constituents with anticonvulsant and anxiolytic activities.</p></caption><graphic xlink:href="molecules-23-01061-g005"/></fig><fig id="molecules-23-01061-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>The terpenes acting on GABA<sub>A</sub> receptors as antagonists.</p></caption><graphic xlink:href="molecules-23-01061-g006"/></fig><table-wrap id="molecules-23-01061-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-23-01061-t001_Table 1</object-id><label>Table 1</label><caption><p>The summary of essential oils from different plants, their pharmacological properties, and mechanism of actions.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">EO Botanical Origins</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Administration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pharmacological Effects</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanism of Actions</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Authors/Year/Ref.</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Achillea Wilhelmsii</italic> C. Koch</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>i.p.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anxiolytic effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">not probably mediated through GABA and opioid receptors</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Majnooni et al., 2013 [<xref rid="B19-molecules-23-01061" ref-type="bibr">19</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Acorus gramineus</italic> Rhizoma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>INH</italic>; <italic>p.o.</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pentylenetetrazole-induced convulsion; sedative effect; CNS inhibitory effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">increased GABA level; decreased GABA transaminase</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Koo et al., 2003 [<xref rid="B20-molecules-23-01061" ref-type="bibr">20</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Acorus tatarinowii</italic> Schott</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">analgesic effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inhibited Na<sup>+</sup> channels</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moreira-Lobo et al., 2010 [<xref rid="B17-molecules-23-01061" ref-type="bibr">17</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Aloysia citrodora</italic> Palau</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">in vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">effective antioxidant, radical-scavenging activities, and neuronal protection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inhibited [<sup>3</sup>H] nicotine binding</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Abuhamdah et al., 2015 [<xref rid="B21-molecules-23-01061" ref-type="bibr">21</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Artemisia herba-alba</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">in vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">antifungal and anti-inflammatory activities</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Abu-Darwish et al., 2015 [<xref rid="B22-molecules-23-01061" ref-type="bibr">22</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Artemisia ludoviciana</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>i.p.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">antinociceptive activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">partially mediated by the opioid system</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anaya-Eugenio et al., 2016 [<xref rid="B23-molecules-23-01061" ref-type="bibr">23</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Artemisia judaica</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">in vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">antifungal and anti-inflammatory activities</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Abu-Darwish et al., 2016 [<xref rid="B24-molecules-23-01061" ref-type="bibr">24</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Artemisia dracunculus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>i.p.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">peripheral and central antinociceptive activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Maham et al., 2014 [<xref rid="B25-molecules-23-01061" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Asarum heterotropoides</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>INH</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">decreased depression-like behaviors</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Park et al., 2015 [<xref rid="B26-molecules-23-01061" ref-type="bibr">26</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Camellia sinensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>INH</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">increased sleeping time</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">potentiated GABA<sub>A</sub> receptors</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hossain et al., 2004 [<xref rid="B27-molecules-23-01061" ref-type="bibr">27</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Citrus aurantium</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>p.o.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anxiolyticlike activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">serotonergic system (5-HT1<sub>A</sub> receptors)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Costa et al., 2013 [<xref rid="B28-molecules-23-01061" ref-type="bibr">28</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Citrus bergamia</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">decreased stress-induced anxiety</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">tuning synaptic plasticity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bagetta et al., 2010 [<xref rid="B29-molecules-23-01061" ref-type="bibr">29</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Citrus sinensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>INH</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">acute anxiolytic activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Faturi et al., 2010 [<xref rid="B30-molecules-23-01061" ref-type="bibr">30</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Coriander</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>INH</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">increased anxiolytic&#x02013;antidepressant-like behaviors, and</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cioanca et al., 2014 [<xref rid="B31-molecules-23-01061" ref-type="bibr">31</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cymbopogon citratus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>p.o.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anxiolytic-like activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">potentiated GABA<sub>A</sub> receptor complex</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Costa et al., 2011 [<xref rid="B13-molecules-23-01061" ref-type="bibr">13</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cymbopogon winterianus</italic> Jowitt; and <italic>C. citratus</italic> (DC) Stapf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>i.p.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anticonvulsant activities</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">via GABAergic neurotransmission</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silva et al., 2010 [<xref rid="B32-molecules-23-01061" ref-type="bibr">32</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Dysphania graveolens</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>p.o.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">antinociceptive effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D&#x000e9;ciga-Campos et al., 2017 [<xref rid="B33-molecules-23-01061" ref-type="bibr">33</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Hyptis mutabilis</italic> (Rich.) <italic>Briq.</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>p.o.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">sedative and central anesthetic activities</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">no involvement of the GABA<sub>A</sub>-BDZ system</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silva et al., 2013 [<xref rid="B34-molecules-23-01061" ref-type="bibr">34</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Lavandula angustifolia</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>INH</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anxiolytic-like effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">serotonergic system</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chioca et al., 2013 [<xref rid="B35-molecules-23-01061" ref-type="bibr">35</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Lippia alba</italic> (Mill.) N.E. Brown</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>p.o.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">central anesthetic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">involvement of the GABAergic system</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Heldwein et al., 2012 [<xref rid="B36-molecules-23-01061" ref-type="bibr">36</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Lemon oil</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anxiolytic, antidepressant-like effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">suppression of DA activity related to enhanced 5-HTnergic neurons</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Komiya et al., 2006 [<xref rid="B37-molecules-23-01061" ref-type="bibr">37</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Melissa officinalis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>p.o.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anti-agitation effects in patients and the depressant effects in in-vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inhibited GABA-induced currents</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Abuhamdah et al., 2008 [<xref rid="B38-molecules-23-01061" ref-type="bibr">38</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Nigella sativa</italic> Seed lmain components</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>p.o.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">potentiation of valproate-induced anticonvulsant effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">increased in GABAergic response</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Raza et al., 2008 [<xref rid="B39-molecules-23-01061" ref-type="bibr">39</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Perfume and phytoncid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>in vitro</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anxiolytic anticonvulsant and sedative activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">potentiating GABA<sub>A</sub> receptors</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aoshima and Hamamoto, 1999 [<xref rid="B40-molecules-23-01061" ref-type="bibr">40</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Piper guineense</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>INH</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">sedative and anxiolytic-like effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tankam and Tto, 2013 [<xref rid="B2-molecules-23-01061" ref-type="bibr">2</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Pistacia integerrima</italic> Stewart ex Brandis Galls</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>in vitro</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">relaxant and spasmolytic effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">involvement of &#x003b2;-adrenoceptors and calcium channels</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shirole et al., 2015 [<xref rid="B41-molecules-23-01061" ref-type="bibr">41</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Salvia sclarea</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>i.p.</italic> or <italic>INH</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anti-depressant-like effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">modulating DAnergic pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Seol et al., 2010 [<xref rid="B42-molecules-23-01061" ref-type="bibr">42</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Syzygium aromaticum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">local anesthesia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited sodium channels</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Huang et al., 2012 [<xref rid="B43-molecules-23-01061" ref-type="bibr">43</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Tagetes minuta</italic> L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>sc</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anxiogenic-like effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">negative modulation on the GABAergic function</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marin et al., 1998 [<xref rid="B44-molecules-23-01061" ref-type="bibr">44</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Thymus capitatus</italic> Hoff. et Link.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>p.o.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">antinociceptive activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">via peripheral nervous excitability blockade</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gon&#x000e7;alves et al., 2017 [<xref rid="B45-molecules-23-01061" ref-type="bibr">45</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Valerian officinalis</italic> L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>p.o.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">sedatives</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Houghton, 1999 [<xref rid="B46-molecules-23-01061" ref-type="bibr">46</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Note: N/A: not applicable; <italic>p.o</italic>.: by mouth, oral; <italic>sc</italic>: subcutaneous injection; <italic>i.p.</italic>: intraperitoneal injection; <italic>INH</italic>: inhalation.</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-23-01061-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-23-01061-t002_Table 2</object-id><label>Table 2</label><caption><p>The summary of pharmacological properties of constituents from essential oils of different plants targeting Na<sup>+</sup> channels and GABAergic system.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Constituents</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pharmacological Effects</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanism of Actions</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Authors/Year/Ref.</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1,8-Cineole</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">antinociceptive, smooth muscle relaxant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">reduction of excitability of peripheral neurons by blocking voltage-dependent Na<sup>+</sup> current</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ferreira-da-Silva et al., 2015 [<xref rid="B64-molecules-23-01061" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">neuronal excitant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hyperexcitability and epileptiform activity in snail neurons by inhibiting potassium channels</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zeraatpisheh and Vatanparast, 2015 [<xref rid="B65-molecules-23-01061" ref-type="bibr">65</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1-Nitro-2-phenylethane</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hypnotic, anti-convulsant and anxiolytic effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oyemitan et al., 2013 [<xref rid="B66-molecules-23-01061" ref-type="bibr">66</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">vasorelaxant effects in rat isolated aortic rings</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inhibition of contractile events that are clearly independent of Ca<sup>2+</sup> influx</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Arruda-Barbosa et al., 2014 [<xref rid="B67-molecules-23-01061" ref-type="bibr">67</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">vasorelaxant effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Interaminense et al., 2013 [<xref rid="B68-molecules-23-01061" ref-type="bibr">68</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(+)-Borneol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">alleviated mechanical hyperalgesia in models of chronic inflammatory and neuropathic pain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">enhanced GABA<sub>A</sub>R-mediated GABAergic transmission</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">JIang et al., 2015 [<xref rid="B69-molecules-23-01061" ref-type="bibr">69</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(+)- and (&#x02212;)-Borneol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">analgesia and anesthesia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">positive modulation of GABA<sub>A</sub>R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Granger et al., 2005 [<xref rid="B14-molecules-23-01061" ref-type="bibr">14</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(+)-Dehydrofukinone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">sedative or anesthetic effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">interacted with GABAergic receptors; a suppressor of neuronal excitability</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Garlet et al., 2016 [<xref rid="B70-molecules-23-01061" ref-type="bibr">70</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(<italic>S</italic>)-Limonene,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-stress effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>via</italic> the GABAergic system</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zhou et al., 2009 [<xref rid="B71-molecules-23-01061" ref-type="bibr">71</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(<italic>R</italic>)-(+)-Limonene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anxiolytic-like effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lima et al., 2013 [<xref rid="B72-molecules-23-01061" ref-type="bibr">72</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(+)-Dehydrofukinone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">sedation, anticonvulsant and anesthesia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">potentiated GABA<sub>A</sub> receptors</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Garlet et al., 2017 [<xref rid="B73-molecules-23-01061" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-asarone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">antiepileptic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">enhanced tonic GABAergic inhibition</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Huang et al., 2013 [<xref rid="B54-molecules-23-01061" ref-type="bibr">54</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">antiepileptic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Na<sup>+</sup> channel blockade and activation of GABA<sub>A</sub> receptors</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wang ZJ et al., 2014 [<xref rid="B4-molecules-23-01061" ref-type="bibr">4</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anticonvulsant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">blocked Na<sup>+</sup> channel, potentiated GABA<sub>A</sub> receptors</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wang ZJ et al., 2014 [<xref rid="B4-molecules-23-01061" ref-type="bibr">4</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-(&#x02212;)-Bisabolol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">antinociceptive-like effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">decreased peripheral nerve excitability probably by blockade of voltage-gated Na<sup>+</sup> channels</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wang YW et al., 2015 [<xref rid="B74-molecules-23-01061" ref-type="bibr">74</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-Pinene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anxiolytic and hypnotic effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">a partial modulator of GABA<sub>A</sub> receptors and directly binding to the benzodiazepine binding site of GABA<sub>A</sub> receptor.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yang et al., 2016 [<xref rid="B75-molecules-23-01061" ref-type="bibr">75</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-Citronellol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypotensive action</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">antagonized transmembrane Ca<sup>2+</sup> influx from the extracellular milieu to produce myorelaxant actions.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vasconcelos et al., 2016 [<xref rid="B76-molecules-23-01061" ref-type="bibr">76</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(<italic>R</italic>)-(&#x02212;)-carvone and (<italic>S</italic>)-(+)-carvone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">antimanic-like effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">blockade of voltage-gated Na<sup>+</sup> channels; activating TRPV1 and TRPA1 channels</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nogoceke et al., 2016 [<xref rid="B77-molecules-23-01061" ref-type="bibr">77</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Benzyl benzoate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anxiolytic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">probably through 5-HTnergic and DAnergic pathways</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alves et al., 2016 [<xref rid="B63-molecules-23-01061" ref-type="bibr">63</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carvacrol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">antinematodal action</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">nicotinic acetylcholine receptors and GABA receptors</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Trailovi&#x00107; et al., 2015 [<xref rid="B78-molecules-23-01061" ref-type="bibr">78</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">analgesic activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">reduced excitability of peripheral neurons; reduced voltage-dependent Na<sup>+</sup> current</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Joca et al., 2012, 2015 [<xref rid="B79-molecules-23-01061" ref-type="bibr">79</xref>,<xref rid="B80-molecules-23-01061" ref-type="bibr">80</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anxiolytic effects in the plus-maze test</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">involvement with GABAergic transmission</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Melo et al., 2010 [<xref rid="B81-molecules-23-01061" ref-type="bibr">81</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Estragole</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anxiolytic and antimicrobial activities</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inhibition of neuronal excitability by blocking Na<sup>+</sup> channels</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silva-Alves et al., 2013 [<xref rid="B82-molecules-23-01061" ref-type="bibr">82</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eugenol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">local analgesic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inhibition of Na<sup>+</sup> channels</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vatanparast, 2017 [<xref rid="B83-molecules-23-01061" ref-type="bibr">83</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">analgesic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">reduced neuronal hyperexcitability by blocking Na<sup>+</sup> currents</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Huang et al., 2012 [<xref rid="B43-molecules-23-01061" ref-type="bibr">43</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inhibition of action potentials</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moreira-Lobo et al., 2010 [<xref rid="B17-molecules-23-01061" ref-type="bibr">17</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Isopulegol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pentylenetetrazol-induced convulsions</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">positive modulation of GABA<sub>A</sub>R and antioxidant properties</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silva et al., 2009 [<xref rid="B84-molecules-23-01061" ref-type="bibr">84</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Linalool</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">antinociceptive effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">blocked excitability by decreasing the voltage-dependent Na<sup>+</sup> current in dorsal root ganglion neurons</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leal-Cardoso et al., 2010 [<xref rid="B85-molecules-23-01061" ref-type="bibr">85</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Menthol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">analgesia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">blocked action potentials in frog sciatic nerves unassociated with TRPM8 activation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kawasaki et al., 2013 [<xref rid="B86-molecules-23-01061" ref-type="bibr">86</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methyleugenol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anticonvulsant, antinociceptive and anesthetic activities</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">agonist of GABA<sub>A</sub> receptors in cultured hippocampal neurons</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ding et al., 2014 [<xref rid="B87-molecules-23-01061" ref-type="bibr">87</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">antinociceptive effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inhibition of NMDA receptor-mediated hyperalgesia via GABA<sub>A</sub> receptors</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yano et al., 2006 [<xref rid="B88-molecules-23-01061" ref-type="bibr">88</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">antinociceptive and anesthetic actions</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inhibition of Na<sub>v</sub>1.7 channels</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wang ZJ et al., 2015 [<xref rid="B5-molecules-23-01061" ref-type="bibr">5</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Myrtenol and Verbenol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">sedative, anxiolytic and anticonvulsive effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">augments phasic and tonic GABAergic inhibition; positive allosteric modulation of GABA<sub>A</sub> receptors</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">van Brederode et al., 2016 [<xref rid="B16-molecules-23-01061" ref-type="bibr">16</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">antinociceptive and anti-inflammatory activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">involvement of the GABAergic system and proinflammatory cytokines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fons&#x000ea;ca et al., 2016 [<xref rid="B89-molecules-23-01061" ref-type="bibr">89</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terpinen-4-ol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anticonvulsant effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">involvement of the GABAergic system, and decrease Na<sup>+</sup> current</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N&#x000f3;brega et al., 2014 [<xref rid="B90-molecules-23-01061" ref-type="bibr">90</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thujone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">muscle spasms and convulsions</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GABA receptor antagonist</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mariani et al., 2016 [<xref rid="B91-molecules-23-01061" ref-type="bibr">91</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thymol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">antinociception</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">nerve conduction inhibition; activated TRPA1 channels; a positive allosteric modulator of human GABA<sub>A</sub>R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xu et al., 2015 [<xref rid="B92-molecules-23-01061" ref-type="bibr">92</xref>] Priestley et al., 2003 [<xref rid="B93-molecules-23-01061" ref-type="bibr">93</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thymoquinone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anticonvulsant effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">opioid receptor-mediated increase in GABAergic tone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hosseinzadeh and Parvardeh, 2004 [<xref rid="B94-molecules-23-01061" ref-type="bibr">94</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Note: N/A: not applicable.</p></fn></table-wrap-foot></table-wrap></floats-group></article>